hematologic disease: A disease involving the hematopoietic system.
Other diseases of blood and blood-forming organs, wide
DOID EFO Endpoint Browser PheWeb
D3_BLOODOTHER
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
9433 |
6. Filter based on genotype QC (FinnGen only) |
9433 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Other diseases of blood and blood-forming organs, wide
based on the number of shared cases.
Similar with more cases:
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 61862 | 33444 | 27962 |
| Only index persons | 52577 | 29034 | 23543 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.87 | 0.96 | 0.78 |
| Only index persons | 0.99 | 1.07 | 0.90 |
| Median age at first event (years) | |||
| Whole population | 59.66 | 59.54 | 59.73 |
| Only index persons | 58.81 | 58.55 | 59.12 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9433 | 5312 | 4121 |
| Unadjusted period prevalence (%) | 1.81 | 1.81 | 1.82 |
| Median age at first event (years) | 59.40 | 56.92 | 62.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 8559
- Matched controls
- 85591
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
5.5
323.0
2000
4496
L03AA13
ATC
pegfilgrastim; parenteral
9.9
323.0
1081
1237
L03AA02
ATC
filgrastim; parenteral
11.5
323.0
837
798
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.5
323.0
2198
4342
L01XX05
ATC
hydroxycarbamide; oral
32.8
323.0
704
233
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
323.0
4762
26262
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.6
323.0
1022
1508
JN4BD
NOMESCO Finland
Extensive body CT
4.1
323.0
1749
5016
D75.1
ICD-10 Finland
Secondary polycythaemia
773.1
323.0
711
10
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
25.6
323.0
528
219
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
290.5
323.0
1091
43
D70.89
ICD-10 Finland
Neutropenic splenomegaly
1450.6
323.0
1644
14
D70.82
ICD-10 Finland
Drug-induced neutropenia
2993.7
323.0
2400
12
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
37.4
323.0
531
151
D75.2
ICD-10 Finland
Essential thrombocytosis
330.1
323.0
830
28
WW500
NOMESCO Finland
Blood transfusion
8.9
323.0
1052
1328
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
323.0
2941
10600
R50.9
ICD-10 Finland
Fever, unspecified
4.4
323.0
2242
6420
D72.1
ICD-10 Finland
Eosinophilia
518.2
323.0
491
10
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
18.8
323.0
1881
1264
A04AA02
ATC
granisetron; systemic, transdermal
6.0
323.0
1254
2392
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
588.4
323.0
655
12
XW000
NOMESCO Finland
Bone marrow biopsy
22.0
323.0
2009
1179
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
323.0
1924
6241
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.2
321.7
834
1267
ZX120
NOMESCO Finland
Intravenous
4.0
318.4
1450
4164
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
14.0
314.3
557
423
A04AA01
ATC
ondansetron; systemic, rectal
4.6
283.1
1075
2577
J01MA12
ATC
levofloxacin; systemic
2.8
269.2
2162
9304
L03AA14
ATC
lipegfilgrastim; parenteral
11.2
266.4
525
498
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
9.3
252.7
550
627
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
126.7
250.9
270
22
N02AA05
ATC
oxycodone; systemic
2.9
230.5
1672
6664
JN4AD
NOMESCO Finland
Body CT examination
3.7
223.3
1070
3143
M04AA01
ATC
allopurinol; systemic
3.0
222.4
1511
5758
D45
ICD-10 Finland
Polycythaemia vera
18.1
221.5
353
203
115
Kela drug reimbursment
Breast cancer
3.6
221.3
1105
3358
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
221.1
3213
18457
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
13.1
217.5
395
314
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.6
195.6
733
1706
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
192.2
3214
19295
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
13.9
190.3
336
250
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
189.5
1192
4274
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
187.4
2296
11997
A02BC02
ATC
pantoprazole; systemic
2.0
185.2
5704
43067
A41.9
ICD-10 Finland
Sepsis, unspecified
5.4
182.1
584
1145
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.4
179.8
386
426
D73.5
ICD-10 Finland
Infarction of spleen
+∞
179.8
172
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
178.6
1104
3900
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.8
177.6
826
2344
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
173.6
1598
7192
H02AB06
ATC
prednisolone; systemic
1.9
172.2
4216
28899
A04AD12
ATC
aprepitant; systemic
7.4
172.0
429
604
D75.0
ICD-10 Finland
Familial erythrocytosis
246.2
165.0
169
7
Z51.5
ICD-10 Finland
Palliative care
3.8
164.8
773
2203
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
50.9
164.0
199
40
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.6
157.5
491
928
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
157.4
1163
4589
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.4
149.9
806
2556
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.7
149.5
299
289
ZX112
NOMESCO Finland
Subcutaneous
6.3
146.2
410
678
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
145.7
2029
11015
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
142.1
2634
15985
A04AA55
ATC
palonosetron, combinations; systemic
5.1
140.0
468
957
D73.1
ICD-10 Finland
Hypersplenism
+∞
135.8
130
*
B01AB05
ATC
enoxaparin; parenteral
1.9
133.2
2753
17285
HA1AA
NOMESCO Finland
X-ray mammography
3.0
132.8
859
3093
C03CA01
ATC
furosemide; systemic
1.9
132.4
2465
14903
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.1
130.4
783
2680
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
129.9
583
1590
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
4.2
129.6
529
1325
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.3
129.1
517
1271
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.3
126.3
235
196
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.6
125.4
465
1060
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
124.8
716
2368
HAC20
NOMESCO Finland
Total mastectomy
3.8
124.5
561
1534
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
120.7
845
3195
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
12.8
120.0
219
175
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
119.8
606
1822
B01AB10
ATC
tinzaparin; parenteral
2.9
117.5
778
2836
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
24.4
117.0
168
70
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
24.9
116.2
166
68
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.7
114.9
411
902
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
14.7
114.2
196
136
L02BG04
ATC
letrozole; oral
3.0
111.7
693
2415
WZC30
NOMESCO Finland
Teaching
2.2
111.2
1302
6458
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
3.1
110.4
663
2259
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
109.1
814
3190
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
7.6
107.3
262
356
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.1
106.3
442
1123
L02BA01
ATC
tamoxifen; oral
3.7
106.2
493
1380
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.1
104.1
612
2053
TGC00
NOMESCO Finland
Bronchial lavation
4.8
103.7
366
791
J01MA14
ATC
moxifloxacin; systemic
2.5
102.7
901
3864
J01DB01
ATC
cefalexin; oral
1.8
101.6
6818
58912
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
100.3
4208
31880
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
98.4
1889
11329
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
330.8
98.2
99
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.0
98.2
622
2193
130
Kela drug reimbursment
Malignant tumour
2.5
97.6
834
3521
L01XX35
ATC
anagrelide; oral
49.8
97.2
118
24
D69.5
ICD-10 Finland
Secondary thrombocytopenia
25.0
97.0
138
56
ZXE00
NOMESCO Finland
One hour or less
1.6
94.3
3338
24023
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
93.6
437
1227
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.0
93.1
270
465
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
92.3
3082
21799
JN6AD
NOMESCO Finland
CT of torso and neck
7.2
92.2
233
333
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
90.9
2339
15342
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
90.8
1022
4943
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
90.8
1815
10992
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.7
89.8
420
1180
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
88.7
588
2133
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
3.0
87.7
533
1825
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
87.4
800
3495
N02BE01
ATC
paracetamol; systemic, rectal
1.8
86.8
7103
62936
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.0
86.1
369
962
C83.1
ICD-10 Finland
Mantle cell lymphoma
18.0
85.4
135
76
PJA12
NOMESCO Finland
Sentinel node biopsy
2.4
84.1
756
3270
127
Kela drug reimbursment
Transplant complication
6.0
83.3
239
406
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
81.1
992
4963
JN4CD
NOMESCO Finland
Very extensive body CT
3.2
79.7
447
1445
SPAT1074
SPAT
Venesection
17.3
78.6
126
74
X76
ICPC
Malignant neoplasm breast female
4.9
78.1
266
553
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
78.0
371
1056
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
8.8
77.7
172
200
D73.9
ICD-10 Finland
Disease of spleen, unspecified
765.2
77.4
76
*
TPH00
NOMESCO Finland
Phlebotomy
11.4
77.2
148
132
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
13.4
76.5
136
103
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.2
76.2
214
354
WW300
NOMESCO Finland
Transfer of autologic stem cells
16.3
75.7
124
77
Z3231
NOMESCO Finland
Registered nurse
1.6
75.5
2311
15755
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
25.5
75.1
106
42
D70.80
ICD-10 Finland
Agranulocytic angina
+∞
75.1
72
*
ZX108
NOMESCO Finland
Inhalation
9.0
75.0
163
184
ZXD05
NOMESCO Finland
Urgent procedure
1.6
74.6
2505
17494
C50.99
ICD-10 Finland
Breast, unspecified
3.9
73.5
324
865
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
4.0
73.4
310
797
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
72.3
872
4322
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
72.0
915
4639
2888B
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOPENIA]
+∞
72.0
69
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
15.4
71.7
120
79
L01BC06
ATC
capecitabine; oral
3.2
71.0
399
1291
D70.81
ICD-10 Finland
Neutropenia congenital
+∞
70.9
68
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
19.9
70.9
108
55
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
69.9
853
4246
N05CF01
ATC
zopiclone; oral
1.6
69.5
2557
18199
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.3
69.3
221
427
B03XA02
ATC
darbepoetin alfa; parenteral
4.7
68.7
244
531
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.2
68.6
382
1228
L03AB05
ATC
interferon alfa-2b; parenteral
15.6
68.5
114
74
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
10.1
67.7
138
139
R4110
NOMESCO Finland
Physiotherapy
1.6
67.4
2181
15004
H02AB09
ATC
hydrocortisone; systemic
4.0
67.4
282
719
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
66.9
1221
7087
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
66.6
1312
7811
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
66.2
2754
20128
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.6
66.2
202
371
WW200
NOMESCO Finland
Immunization
3.5
65.7
322
939
D70
ICD-10 Finland
Agranulocytosis
643.0
65.0
64
*
N02AX02
ATC
tramadol; systemic, rectal
1.5
65.0
3345
25627
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.9
64.5
186
319
J01MA02
ATC
ciprofloxacin; systemic
1.5
64.4
3033
22771
WX402
NOMESCO Finland
General anaesthesia
1.8
64.2
1357
8255
M05BX04
ATC
denosumab; parenteral
2.7
63.1
462
1774
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
5.3
62.6
200
388
Z2446
NOMESCO Finland
Social worker
2.3
62.4
605
2705
J05AB11
ATC
valaciclovir; oral
1.9
62.3
1091
6230
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
17.0
61.5
99
59
D73.4
ICD-10 Finland
Cyst of spleen
+∞
61.5
59
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
5.5
61.1
189
353
A06AD11
ATC
lactulose; oral
1.8
60.9
1135
6614
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
60.4
3200
24546
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
60.4
1706
11268
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.2
60.1
238
577
A46
ICD-10 Finland
Erysipelas
1.8
59.5
1120
6544
ZX080
NOMESCO Finland
Image guided radiotherapy
3.9
59.2
258
682
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.0
58.6
246
629
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.7
58.5
205
440
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
58.3
658
3154
L02BG06
ATC
exemestane; oral
4.9
57.1
193
399
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
57.1
1151
6874
L04AA06
ATC
mycophenolic acid; systemic
4.4
56.7
213
491
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.4
55.9
521
2280
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
4.6
55.9
200
439
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
6.5
55.9
149
231
YNB10
NOMESCO Finland
Collection of stem cells for transplant
30.2
55.9
75
25
B99
ICPC
Blood/lymph/spleen disease other
13.2
55.6
99
76
NK6AN
NOMESCO Finland
Total body bone isotope imaging
3.2
54.1
305
989
UJF32
NOMESCO Finland
Coloscopy
1.5
54.0
2016
14223
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
32.5
53.9
71
22
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
53.3
982
5683
R11
ICD-10 Finland
Nausea and vomiting
2.1
53.1
660
3297
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
15.6
53.1
88
57
Z31.5
ICD-10 Finland
Genetic counselling
2.5
53.0
428
1738
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
15.7
52.6
87
56
1XC02
NOMESCO Finland
NA
6.9
52.5
135
199
28899
ICD-8 Finland
Agranulocytosis
+∞
52.1
50
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
29.4
51.8
70
24
A41.8
ICD-10 Finland
Other specified sepsis
4.4
51.7
196
456
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
51.7
1372
8864
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.0
51.7
309
1042
212
Kela drug reimbursment
Gout
3.8
51.5
225
597
1CD02
NOMESCO Finland
NA
6.8
51.1
132
196
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
27.1
50.7
70
26
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
21.0
50.4
75
36
R06.0
ICD-10 Finland
Dyspnoea
1.5
50.3
1898
13387
189
Kela drug reimbursment
Imatinib
15.1
50.1
84
56
Z3226
NOMESCO Finland
Physiotherapist
1.6
50.0
1478
9817
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
49.5
400
1623
D73.8
ICD-10 Finland
Other diseases of spleen
490.7
49.4
49
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
49.4
664
3423
SPAT1255
SPAT
Intravenous administration of medicine
2.2
49.3
558
2676
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
49.3
636
3225
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
15.3
49.2
82
54
L04AD01
ATC
ciclosporin; systemic
3.7
49.2
222
606
WX110
NOMESCO Finland
Local anesthesy
1.4
49.1
5350
46361
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
3.6
48.8
229
646
N05AH02
ATC
clozapine; systemic
3.9
48.6
206
532
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
19.4
47.8
73
38
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
47.7
570
2797
JMA10
NOMESCO Finland
Transabdominal total splenectomy
8.4
47.6
107
129
Z2221
NOMESCO Finland
Medical doctor
1.5
47.6
2158
15824
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.9
47.4
203
530
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
47.3
464
2081
C91.7
ICD-10 Finland
Other lymphoid leukaemia
47.8
47.0
57
12
L01CB01
ATC
etoposide; systemic
9.3
47.0
99
107
R53
ICD-10 Finland
Malaise and fatigue
1.6
46.7
1500
10157
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.3
46.3
245
759
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
45.9
500
2356
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.6
45.5
351
1386
N05BA04
ATC
oxazepam; oral
1.5
45.3
1845
13186
D73.0
ICD-10 Finland
Hyposplenism
450.1
45.3
45
*
C90.0
ICD-10 Finland
Multiple myeloma
5.4
45.2
139
259
N03AX16
ATC
pregabalin; oral
1.5
45.0
1799
12802
J01FF01
ATC
clindamycin; systemic
1.5
44.9
2060
15109
WF004
NOMESCO Finland
Palliative radiotherapy
3.6
44.8
208
582
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
12.2
44.1
81
67
N05BA06
ATC
lorazepam; systemic, sublingual
2.3
44.1
434
1948
ZX121
NOMESCO Finland
Central venous catheter
9.7
44.1
91
95
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
43.9
732
4080
28900
ICD-8 Finland
Other disease of blood and blood-forming organs, Polycythaemia, secondary
+∞
43.8
42
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.0
43.1
143
291
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
4.1
43.0
173
427
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
10.5
42.9
85
82
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
42.9
1270
8404
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
3.4
42.9
215
640
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
12.7
42.8
77
61
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
42.7
41
*
N05AH03
ATC
olanzapine; systemic
2.2
42.4
476
2272
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
42.3
666
3637
A02BC01
ATC
omeprazole; systemic
1.5
42.3
2082
15454
A05AA02
ATC
ursodeoxycholic acid; oral
3.9
42.3
180
468
ZY010
NOMESCO Finland
Hospital outpatient
2.3
42.1
392
1715
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.2
41.7
224
702
A07AA02
ATC
nystatin; oral
2.1
41.7
519
2589
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
9.2
41.6
88
96
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.9
41.6
258
893
HAB40
NOMESCO Finland
Wedge excision of mammary gland
2.2
41.5
427
1956
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
17.0
41.4
66
39
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
17.0
41.4
66
39
TQW20
NOMESCO Finland
Tatoe
4.8
41.4
143
304
C07AB07
ATC
bisoprolol; oral
1.4
41.1
3496
28637
L01XE01
ATC
[U] imatinib; oral
14.4
41.1
70
49
ED1AA
NOMESCO Finland
Mandipular X-ray examination
7.2
41.1
102
144
192
Kela drug reimbursment
Fulvestrant
9.0
40.9
88
99
L01BB05
ATC
fludarabine; systemic
21.6
40.8
60
28
128
Kela drug reimbursment
Cancers of female genital organs
3.8
40.8
181
488
L01CA04
ATC
vinorelbine; systemic
5.8
40.7
119
209
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.8
40.6
178
475
A02BC05
ATC
esomeprazole; systemic
1.4
40.5
3037
24333
WX892
NOMESCO Finland
Monitored bed care
1.9
40.3
611
3291
AA1AD
NOMESCO Finland
CT of head and brain
1.5
40.2
1757
12705
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
40.1
3049
24475
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.8
39.7
115
200
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
12.1
39.7
73
61
D76.3
ICD-10 Finland
Other histiocytosis syndromes
+∞
39.6
38
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
3.3
39.4
211
660
E0000UV
ATC
NA
1.4
39.4
2938
23484
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
39.3
1309
8900
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
12.5
39.3
71
57
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.2
39.2
416
1934
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.8
39.1
101
151
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.5
39.0
315
1278
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.9
38.7
165
430
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.6
38.6
288
1119
L03AB04
ATC
interferon alfa-2a; parenteral
17.1
38.4
61
36
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
38.1
2080
15697
A28
ICPC
Limited function/disability NOS
1.6
38.1
1036
6688
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.2
38.0
204
640
P01AB01
ATC
metronidazole; oral, rectal
1.4
37.9
2922
23444
SPAT1254
SPAT
Administration of medicine
1.6
37.6
1076
7038
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.2
37.4
147
356
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.0
37.4
221
741
L02BA03
ATC
fulvestrant; parenteral
7.9
37.1
86
110
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
17.7
37.0
58
33
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
6.1
36.9
103
171
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.1
36.9
209
681
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
10.4
36.8
73
71
A79
ICPC
Malignancy NOS
4.1
36.8
146
357
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
36.7
256
955
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
36.6
495
2552
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.6
36.5
170
478
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
3.9
36.5
157
413
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
29.0
36.4
49
17
J05AB01
ATC
aciclovir; systemic
1.5
36.3
1524
10892
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
36.3
716
4210
H02AB07
ATC
prednisone; oral
1.6
36.2
1075
7091
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
36.2
389
1820
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
26.4
36.2
50
19
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.1
36.1
419
2028
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
35.9
451
2256
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.1
35.7
445
2217
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
35.7
306
1283
J02AC03
ATC
voriconazole; systemic
15.2
35.6
59
39
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
35.3
1284
8892
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
12.7
35.1
63
50
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
35.0
983
6388
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
4.3
34.9
132
309
L04AX01
ATC
azathioprine; systemic
2.2
34.8
366
1694
390
Kela drug reimbursment
Ibrutinib
20.1
34.7
52
26
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
34.7
480
2492
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
6.3
34.5
93
148
R06AE07
ATC
cetirizine; oral
1.3
34.4
3197
26314
28998
ICD-8 Finland
Other disease of blood and blood-forming organs, Alii definiti
+∞
34.4
33
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.1
34.3
396
1911
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
10.2
34.1
68
67
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.1
34.1
110
218
C03DA01
ATC
spironolactone; oral
1.7
33.9
766
4690
WX002
NOMESCO Finland
Sedation and analgesia
1.5
33.7
1462
10504
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.3
33.7
176
542
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
45.7
33.7
41
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
33.5
790
4895
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
5.1
33.5
108
214
B73
ICPC
Leukaemia
21.4
33.4
49
23
C50
ICD-10 Finland
Malignant neoplasm of breast
2.9
33.2
206
715
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
3.8
33.2
145
387
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
33.1
182
582
174
Kela drug reimbursment
Ruxolitinib
33.2
33.1
43
13
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
32.9
883
5667
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
4.8
32.8
111
232
SPAT1262
SPAT
Handing over of treatment supplies
1.5
32.7
1341
9514
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
5.1
32.6
104
204
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
32.3
409
2054
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
11.2
32.1
61
55
J01CA04
ATC
amoxicillin; systemic
1.4
32.1
6309
57757
S18
ICPC
Laceration/cut
1.3
32.0
3086
25457
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
3.6
31.8
149
422
ZX131
NOMESCO Finland
Intrathecal
43.5
31.8
39
9
C82.1
ICD-10 Finland
Follicular lymphoma grade II
5.7
31.8
93
165
SPAT1088
SPAT
Blood transfusion
7.4
31.7
76
103
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
3.0
31.6
189
641
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
31.5
341
1601
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
16.0
31.5
51
32
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
31.4
296
1302
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.2
31.3
121
290
1501
Kela drug reimbursment
Palbociclib
7.0
31.3
78
112
1512
Kela drug reimbursment
Ibrutinib
19.7
31.2
47
24
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
31.2
549
3109
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
31.7
31.2
41
13
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
9.9
31.2
63
64
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.7
31.0
108
233
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
31.0
1483
10846
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
2.9
31.0
196
689
3AA02
NOMESCO Finland
NA
70.1
30.9
35
5
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.7
30.7
212
785
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
2.8
30.7
201
724
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
8.0
30.6
70
88
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
30.5
3119
25901
R03AC02
ATC
salbutamol; inhalant
1.3
30.4
3867
33118
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.9
30.4
189
658
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
11.0
30.4
58
53
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
30.4
413
2132
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.9
30.3
101
208
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
6.4
30.3
81
128
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
30.2
1160
8102
D76.00
ICD-10 Finland
Eosinophilic granuloma
+∞
30.2
29
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
30.1
808
5180
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
30.1
363
1783
TAB00
NOMESCO Finland
Lumbar puncture
2.1
30.1
340
1626
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
3.2
30.1
163
517
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
30.0
518
2913
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.5
29.9
244
996
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.4
29.9
151
454
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
29.9
976
6574
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.7
29.8
134
367
RS220
NOMESCO Finland
NA
3.5
29.8
141
403
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
4.7
29.8
103
221
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.0
29.7
417
2179
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
4.1
29.6
118
291
SPAT1263
SPAT
Sampling
1.3
29.5
3131
26100
L02BG03
ATC
anastrozole; oral
3.2
29.3
159
505
J02AC01
ATC
fluconazole; systemic
1.3
29.2
2800
22994
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
18.1
29.1
45
25
WW409
NOMESCO Finland
Other aferesis
10.1
29.0
58
58
374
Kela drug reimbursment
Ruxolitinib
31.8
29.0
38
12
C91.4
ICD-10 Finland
Hairy-cell leukaemia
31.8
29.0
38
12
B01AB04
ATC
dalteparin; parenteral
2.0
29.0
382
1949
FM1FN
NOMESCO Finland
Heart function isotope examination
5.7
28.9
84
148
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.5
28.8
139
404
N05AH04
ATC
quetiapine; oral
1.5
28.7
1096
7639
A03
ICPC
Fever
1.5
28.6
1050
7259
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
28.5
2653
21674
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
29.3
28.4
38
13
TPX15
NOMESCO Finland
Removal of vascular injection port
6.5
28.3
74
114
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
9.9
28.3
57
58
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.3
28.2
272
1211
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.2
28.2
89
173
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
3.4
28.2
140
416
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
28.2
234
966
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
28.2
528
3051
D72.0
ICD-10 Finland
Genetic anomalies of leukocytes
+∞
28.1
27
*
28999
ICD-8 Finland
Other disease of blood and blood-forming organs, Other and unspecified
+∞
28.1
27
*
2880B
ICD-9 Finland
Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, E MEDICAMENTIS]
+∞
28.1
27
*
TK800
NOMESCO Finland
Hemodialysis
2.8
28.1
186
675
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
3.2
28.1
154
493
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
28.0
219
876
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
11.1
27.9
53
48
ZXA00
NOMESCO Finland
Right side
1.4
27.7
1954
15275
R18
ICD-10 Finland
Ascites
3.1
27.7
160
531
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
3.2
27.5
151
484
L28
ICPC
Limited function/disability (L)
1.5
27.4
1065
7447
N06AX16
ATC
venlafaxine; oral
1.5
27.4
949
6470
L01XE33
ATC
[U] palbociclib; oral
8.4
27.1
60
72
L01XE27
ATC
[U] ibrutinib; oral
21.8
26.9
39
18
Z51.0
ICD-10 Finland
Radiotherapy session
3.5
26.8
126
359
B02.9
ICD-10 Finland
Zoster without complication
1.9
26.6
410
2218
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
26.6
558
3337
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
34.1
26.4
34
10
ZZF00
NOMESCO Finland
Graft of adipose tissue
4.4
26.3
97
223
JAH00
NOMESCO Finland
Laparotomy
2.5
26.3
217
892
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
26.2
281
1315
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
26.1
316
1558
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
26.1
357
1847
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
4.5
26.0
94
212
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
19.6
26.0
39
20
R4190
NOMESCO Finland
Nutritional therapy
2.2
26.0
262
1193
L01AA02
ATC
chlorambucil; oral
9.2
25.8
54
59
N06AX11
ATC
mirtazapine; oral
1.3
25.8
2215
17819
A06AH03
ATC
naloxegol; oral
3.8
25.7
112
300
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
25.7
580
3542
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
11.8
25.6
47
40
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
25.6
1167
8424
B72
ICPC
Hodgkin Lymphoma
20.1
25.6
38
19
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
4.5
25.5
92
207
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.3
25.4
239
1054
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
25.2
460
2636
316
Kela drug reimbursment
Imatinib
17.8
25.2
39
22
ZXA05
NOMESCO Finland
Left side
1.4
25.2
1811
14168
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
25.2
1224
8946
A07AA09
ATC
vancomycin; oral
3.4
25.0
124
369
394
Kela drug reimbursment
Palbociclib
6.5
25.0
65
100
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
25.0
3327
28404
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
6.0
25.0
69
115
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.7
24.9
170
629
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
7.9
24.8
57
73
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
17.0
24.8
39
23
R03BB04
ATC
tiotropium bromide; inhalant
1.6
24.6
691
4476
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
15.4
24.5
40
26
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
2.9
24.5
149
514
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
24.4
527
3179
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.0
24.4
144
487
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
2.1
24.3
298
1477
WF002
NOMESCO Finland
Radical radiotherapy
1.9
24.3
355
1883
B01AA03
ATC
warfarin; systemic
1.4
24.2
1336
9984
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
24.2
2800
23442
K92.1
ICD-10 Finland
Melaena
1.9
24.1
355
1887
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
24.1
153
543
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
24.0
1209
8886
D71
ICD-10 Finland
Functional disorders of polymorphonuclear neutrophils
+∞
24.0
23
*
L01AA01
ATC
cyclophosphamide; systemic
6.9
23.9
60
88
6BA02
NOMESCO Finland
NA
7.8
23.9
55
71
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
5.4
23.8
72
134
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
23.7
828
5649
122
Kela drug reimbursment
Aplastic anaemia
31.1
23.7
31
10
L01XE18
ATC
[U] ruxolitinib; oral
31.1
23.7
31
10
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.8
23.6
153
548
L01EJ01
ATC
ruxolitinib; oral
41.5
23.6
29
7
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.1
23.5
131
426
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
3.6
23.4
107
299
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
23.4
1013
7231
S97
ICPC
Chronic ulcer skin
1.8
23.3
380
2098
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.6
23.3
82
181
N05BA01
ATC
diazepam; systemic, rectal
1.5
23.1
929
6531
3AA13
NOMESCO Finland
NA
8.3
23.0
51
62
D73.3
ICD-10 Finland
Abscess of spleen
+∞
22.9
22
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
11.7
22.9
42
36
5BA08
NOMESCO Finland
NA
5.3
22.8
70
133
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
7.8
22.6
52
67
TGD00
NOMESCO Finland
Needle biopsy of lung
5.5
22.5
67
123
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
22.5
463
2752
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.4
22.4
187
776
R60.0
ICD-10 Finland
Localized oedema
1.5
22.4
744
5014
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
32.3
22.4
29
9
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
22.4
202
874
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
7.6
22.2
52
69
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.3
22.2
114
350
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.0
22.1
281
1412
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
22.0
258
1258
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
3.5
22.0
103
295
B28
ICPC
Limited function/disability (B)
6.3
21.9
58
92
D76.01
ICD-10 Finland
Histiocytosis X (chronic)
+∞
21.9
21
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
21.8
441
2610
R71
ICD-10 Finland
Abnormality of red blood cells
9.6
21.7
44
46
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.9
21.7
132
456
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.7
21.6
62
109
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
21.6
463
2784
1BC07
NOMESCO Finland
NA
115.3
21.6
23
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.0
21.6
288
1480
B34.9
ICD-10 Finland
Viral infection, unspecified
2.3
21.5
193
833
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
15.3
21.4
35
23
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
21.3
623
4073
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
7.9
21.1
48
61
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
14.6
21.1
35
24
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.0
21.0
85
215
H02AB04
ATC
methylprednisolone; systemic
1.4
21.0
997
7238
B03XA01
ATC
erythropoietin; parenteral
4.1
21.0
82
201
JAH01
NOMESCO Finland
Laparoscopy
1.9
20.9
301
1587
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
20.9
501
3110
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
20.8
440
2639
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.6
20.6
151
582
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
20.6
338
1871
M05BA04
ATC
alendronic acid; oral
1.6
20.6
539
3427
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
4.0
20.6
82
205
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
20.5
1087
8050
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.1
20.4
114
373
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.3
20.3
183
792
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
20.3
636
4229
N05CD07
ATC
temazepam; oral
1.5
20.2
826
5816
P01BA02
ATC
hydroxychloroquine; oral
1.6
20.2
565
3652
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.5
20.2
639
4256
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.6
20.2
152
597
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
20.1
266
1363
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.0
20.0
116
388
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
4.2
20.0
77
186
WNF00
NOMESCO Finland
Infection source and contact determination
5.7
20.0
57
100
N05AD01
ATC
haloperidol; systemic
2.1
19.9
217
1026
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.6
19.9
91
256
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
6.6
19.9
51
78
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
6.4
19.8
52
82
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.5
19.8
158
643
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
7.1
19.7
48
68
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
19.6
2661
22571
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
19.6
483
3020
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
19.6
1818
14687
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.4
19.6
97
291
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.1
19.5
108
351
WW402
NOMESCO Finland
Leucoferesis
12.1
19.5
35
29
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
40.1
19.5
24
6
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
21.6
19.4
28
13
N05AA02
ATC
levomepromazine; systemic
1.9
19.4
293
1575
ZX114
NOMESCO Finland
Intramuscular
2.8
19.4
123
437
188
Kela drug reimbursment
Psychosis requiring demanding treatment
3.3
19.3
96
289
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
8.8
19.3
41
47
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
2.8
19.1
126
458
R50.8
ICD-10 Finland
Other specified fever
4.7
19.0
65
140
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.2
18.9
190
867
ZX100
NOMESCO Finland
Oral
2.9
18.9
117
410
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
2.6
18.9
142
559
PJW99
NOMESCO Finland
Other operation on lymphatic system
5.5
18.9
56
103
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
18.8
513
3293
J01AA02
ATC
doxycycline; systemic
1.2
18.8
5930
55133
B74
ICPC
Malignant neoplasm blood other
9.1
18.8
39
43
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
18.7
1231
9441
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.0
18.7
74
184
D64.8
ICD-10 Finland
Other specified anaemias
2.8
18.7
120
430
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.3
18.7
168
726
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.4
18.7
67
152
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
18.7
67
152
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
4.8
18.7
62
130
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
18.7
254
1314
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.5
18.6
147
595
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
4.0
18.6
75
190
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
18.6
437
2700
N03AG01
ATC
valproic acid; systemic, rectal
1.7
18.6
393
2356
1CX01
NOMESCO Finland
NA
9.3
18.5
38
41
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.4
18.5
156
655
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.3
18.3
163
702
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.2
18.2
196
922
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
9.8
18.1
36
37
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
18.0
700
4880
J02AC04
ATC
posaconazole; systemic
32.9
17.9
23
7
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.4
17.9
64
145
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.4
17.9
86
253
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
17.8
386
2329
N04AA02
ATC
biperiden; systemic
2.4
17.8
150
627
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
17.8
2788
23983
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.1
17.8
96
308
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.5
17.8
583
3914
N05AX12
ATC
aripiprazole; systemic
2.0
17.7
236
1211
A10AE04
ATC
insulin glargine; parenteral
1.5
17.7
603
4084
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.6
17.7
431
2687
UKC02
NOMESCO Finland
Cystoscopy
1.4
17.7
1048
7898
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
3.5
17.6
82
235
B04
ICPC
Blood symptom/complaint
5.1
17.6
55
108
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.6
17.6
80
225
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.5
17.6
143
588
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
15.6
17.4
28
18
N28.0
ICD-10 Finland
Ischaemia and infarction of kidney
8.0
17.4
39
49
L04AA01
ATC
[U] ciclosporin; systemic
2.6
17.3
127
492
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.4
17.3
83
244
-50
ICPC
Medication/prescr/renewal
1.8
17.3
296
1665
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
4.1
17.2
67
165
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
2.6
17.2
124
478
WX702
NOMESCO Finland
Supraglottic ventilation device
1.7
17.1
352
2093
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
3.8
17.1
72
190
3AC01
NOMESCO Finland
NA
3.1
17.1
95
311
1XC03
NOMESCO Finland
NA
5.7
17.1
49
87
E87.6
ICD-10 Finland
Hypokalaemia
2.0
17.1
207
1024
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
17.1
836
6093
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
6.3
17.1
45
72
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
17.0
165
741
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.3
17.0
152
658
R04.0
ICD-10 Finland
Epistaxis
1.6
17.0
457
2925
J94.8
ICD-10 Finland
Other specified pleural conditions
2.7
17.0
117
437
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.3
16.9
152
659
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
9.0
16.8
35
39
152
Kela drug reimbursment
Nilotinib
21.9
16.8
24
11
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
3.5
16.8
79
229
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
5.1
16.7
52
102
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
16.7
214
1085
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.5
16.7
79
230
HAB99
NOMESCO Finland
Other partial excision of mammary gland
2.2
16.7
173
800
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
4.6
16.7
57
124
ZX095
NOMESCO Finland
Combined chemoradiotherapy
4.0
16.6
66
166
B01AC14
ATC
[U] anagrelide; oral
90.2
16.5
18
*
D07AC01
ATC
betamethasone; topical
1.2
16.5
2335
19810
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
16.5
2110
17697
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
3.2
16.4
85
265
L01XX52
ATC
venetoclax; oral
17.9
16.4
25
14
Z94.0
ICD-10 Finland
Kidney transplant status
3.1
16.3
90
294
A02BC03
ATC
lansoprazole; oral
1.3
16.3
1996
16654
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.2
16.3
163
744
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
3.9
16.3
67
174
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.0
16.2
91
301
TQW80
NOMESCO Finland
Local dermatologic skincare
2.1
16.2
185
897
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
16.1
295
1693
Z94.2
ICD-10 Finland
Lung transplant status
9.2
16.1
33
36
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
12.8
16.1
28
22
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
16.1
463
3016
L01EL01
ATC
ibrutinib; oral
16.7
16.0
25
15
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
24.5
16.0
22
9
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.2
15.9
156
707
E000001
ATC
NA
1.3
15.9
1351
10747
ZXA10
NOMESCO Finland
Bilateral
1.3
15.9
1246
9798
L01EF01
ATC
palbociclib; oral
6.9
15.8
39
57
J96.1
ICD-10 Finland
Chronic respiratory failure
2.3
15.7
140
604
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
15.7
762
5541
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.6
15.7
114
442
WX882
NOMESCO Finland
High dependency care
2.0
15.7
203
1031
2888A
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOSIS]
+∞
15.6
15
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
2.3
15.6
146
647
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
2.0
15.6
205
1050
163
Kela drug reimbursment
Abiraterone and enzalutamide
3.4
15.6
75
222
Z2445
NOMESCO Finland
Psychologist
1.8
15.6
249
1369
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.3
15.6
77
233
ZZR10
NOMESCO Finland
Flap of skin and muscle
3.4
15.5
75
223
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
15.5
1483
11985
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.9
15.5
227
1211
399
Kela drug reimbursment
Venetoclax
13.7
15.5
26
19
A29
ICPC
General symptom/complaint other
1.4
15.4
694
4978
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
1.9
15.4
214
1122
HAE99
NOMESCO Finland
Other reconstruction of breast
3.5
15.4
72
209
T90
ICPC
Diabetes non-insulin dependent
1.3
15.3
1495
12112
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
4.0
15.2
61
155
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.7
15.2
349
2145
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.8
15.2
267
1516
C83.00
ICD-10 Finland
Lymphocytic lymphoma
5.9
15.2
42
72
Z71.8
ICD-10 Finland
Other specified counselling
1.3
15.1
1546
12597
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.7
15.1
65
176
J01DA01
ATC
[U] cefalexin; systemic
1.2
15.1
4560
41685
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
45.0
15.0
18
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
15.0
586
4084
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
3.3
15.0
76
234
D69.0
ICD-10 Finland
Allergic purpura
4.1
15.0
58
143
A07EA06
ATC
budesonide; oral, local oral
1.9
15.0
225
1212
D69.4
ICD-10 Finland
Other primary thrombocytopenia
13.9
15.0
25
18
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.8
14.9
264
1501
XX9CD
NOMESCO Finland
Very extensive complementary CT
10.0
14.9
29
29
N05AF05
ATC
zuclopenthixol; systemic
2.9
14.8
87
297
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
14.8
1626
13366
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
14.8
304
1811
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.7
14.8
97
356
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
14.8
720
5238
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.5
14.7
442
2910
J45.1
ICD-10 Finland
Nonallergic asthma
1.5
14.7
452
2991
L03AA04
ATC
NA
8.2
14.7
32
39
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
14.7
471
3149
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
14.6
294
1740
L02BB04
ATC
enzalutamide; oral
3.7
14.6
64
176
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.7
14.6
49
105
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
21.0
14.6
21
10
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
14.6
1946
16362
D73.2
ICD-10 Finland
Chronic congestive splenomegaly
+∞
14.6
14
*
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
80.2
14.6
16
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
14.6
732
9646
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
14.5
551
3816
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
5.0
14.5
46
93
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
4.0
14.5
57
143
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.8
14.5
94
341
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.9
14.4
214
1148
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
14.4
534
3685
N05CF02
ATC
zolpidem; oral
1.3
14.4
1133
8904
K29.7
ICD-10 Finland
Gastritis, unspecified
1.8
14.4
226
1238
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
12.5
14.3
25
20
M10.9
ICD-10 Finland
Gout, unspecified
1.6
14.3
397
2562
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.1
14.3
157
749
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.1
14.3
76
243
L02AE03
ATC
goserelin; implant
2.8
14.3
91
328
L01XX28
ATC
[D] imatinib; oral
27.2
14.2
19
7
150
Kela drug reimbursment
Dasatinib
19.1
14.2
21
11
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.9
14.1
83
284
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
14.1
376
2406
SPAT1153
SPAT
Removal of sutures
1.2
14.1
2203
18841
A01AB09
ATC
miconazole; local oral
1.5
14.1
562
3936
SPAT1229
SPAT
Assessment of need for aid
1.5
14.0
502
3436
UDC00
NOMESCO Finland
Ear microscopy
1.5
14.0
458
3074
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
14.0
348
2184
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
8.0
14.0
31
39
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
14.0
412
2697
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
14.0
2763
24196
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.3
14.0
125
542
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
8.4
13.9
30
36
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.5
13.9
461
3102
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
13.9
353
2231
R31
ICD-10 Finland
Unspecified haematuria
1.4
13.8
608
4336
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
13.8
451
3026
R4120
NOMESCO Finland
Occupational therapy
1.6
13.8
404
2645
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.5
13.8
109
444
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.7
13.7
94
353
F20.10
ICD-10 Finland
Raise schizophrenia continuously
4.9
13.6
44
91
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.9
13.6
201
1075
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
4.6
13.6
46
100
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
12.0
13.5
24
20
GEA00
NOMESCO Finland
Mediastinoscopy
4.5
13.5
47
105
N05AX08
ATC
risperidone; systemic
1.5
13.5
455
3075
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
5.7
13.5
38
67
KFC00
NOMESCO Finland
Unilateral orchiectomy
3.9
13.5
54
138
UJF92
NOMESCO Finland
Capsular endoscopy
2.2
13.5
138
638
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
10.9
13.5
25
23
N03AX09
ATC
lamotrigine; oral
1.7
13.5
272
1612
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
13.5
522
3637
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
4.5
13.4
47
106
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
12.8
13.4
23
18
J32.4
ICD-10 Finland
Chronic pansinusitis
2.5
13.3
103
415
JAL30
NOMESCO Finland
Omentectomy
2.8
13.3
85
308
L01XE06
ATC
[U] dasatinib; systemic
21.1
13.3
19
9
RS221
NOMESCO Finland
NA
2.5
13.3
106
435
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
1.9
13.2
206
1123
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
8.1
13.2
29
36
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
13.2
756
5655
WX872
NOMESCO Finland
Intensive care
1.6
13.2
320
1998
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
13.2
1760
14775
N05AF03
ATC
chlorprothixene; systemic
2.0
13.2
175
902
I81
ICD-10 Finland
Portal vein thrombosis
5.0
13.1
41
82
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.2
13.1
67
209
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.0
13.1
166
840
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
13.1
523
3660
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.1
13.1
140
660
N03AE01
ATC
clonazepam; systemic
1.6
13.1
368
2388
1AA09
NOMESCO Finland
NA
12.1
13.1
23
19
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.6
13.0
94
365
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.6
13.0
313
1952
N05AA01
ATC
chlorpromazine; systemic, rectal
2.5
13.0
101
410
2AX04
NOMESCO Finland
NA
16.7
13.0
20
12
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
4.5
12.9
45
101
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
28.4
12.9
17
6
ZY000
NOMESCO Finland
Hospital inpatient
2.7
12.9
87
326
B29
ICPC
Lymph/immune mech sympt/complt other
4.8
12.9
42
88
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
12.9
476
3284
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
12.9
1100
8739
XX1AD
NOMESCO Finland
Other CT-examination
3.5
12.8
59
170
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
4.2
12.8
48
116
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.6
12.7
92
358
D58.2
ICD-10 Finland
Other haemoglobinopathies
14.0
12.7
21
15
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.4
12.7
106
447
B37.08
ICD-10 Finland
Other candidal stomatitis
3.3
12.7
62
188
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.9
12.6
193
1045
J96.0
ICD-10 Finland
Acute respiratory failure
2.7
12.6
87
328
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
3.8
12.6
52
137
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
3.7
12.6
53
142
J01FA06
ATC
roxithromycin; oral
1.2
12.6
2745
24201
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.0
12.5
159
804
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.1
12.5
137
655
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.5
12.5
99
406
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
12.5
641
4706
2883X
ICD-9 Finland
Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]
+∞
12.5
12
*
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
4.7
12.5
41
87
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.2
12.5
126
581
L01BB02
ATC
mercaptopurine; oral
2.8
12.4
80
292
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
3.6
12.4
55
154
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.1
12.4
131
616
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.6
12.4
320
2031
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
12.4
348
2255
E89.4
ICD-10 Finland
Postprocedural ovarian failure
13.2
12.4
21
16
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
1.9
12.4
167
868
N03AX12
ATC
gabapentin; oral
1.3
12.4
989
7782
A11CC03
ATC
alfacalcidol; systemic
2.0
12.4
149
740
D07AA02
ATC
hydrocortisone; topical
1.3
12.4
834
6405
R05
ICD-10 Finland
Cough
1.3
12.3
1243
10084
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
12.3
346
2244
R51.80
ICD-10 Finland
Headache
1.3
12.3
892
6925
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.3
12.3
112
494
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
12.3
1546
12884
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
5.0
12.2
38
76
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.1
12.2
130
615
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.0
12.2
67
221
SPAT1260
SPAT
Consultation of another employee
1.3
12.2
1160
9344
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
4.5
12.2
42
94
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.5
12.1
392
2627
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
15.9
12.1
19
12
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
12.1
507
3586
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
12.1
719
5411
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
3.3
12.1
59
179
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
4.2
12.1
44
104
C09AA05
ATC
ramipril; oral
1.2
12.0
1570
13129
R04.2
ICD-10 Finland
Haemoptysis
1.8
12.0
209
1185
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.1
12.0
45
109
JAH21
NOMESCO Finland
Staging laparoscopy
26.7
12.0
16
6
B84
ICPC
Unexplained abnormal white cells
26.7
12.0
16
6
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.7
12.0
267
1631
M79.6
ICD-10 Finland
Pain in limb
1.2
12.0
2372
20697
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.0
12.0
158
815
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
4.1
12.0
46
114
JN5AN
NOMESCO Finland
Total body isotope imaging
11.0
12.0
22
20
H03AA01
ATC
levothyroxine sodium; systemic
1.2
12.0
1516
12635
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.1
12.0
137
666
C83.71
ICD-10 Finland
Burkitt's tumour
21.3
12.0
17
8
SPAT1211
SPAT
Application of soft bandage
1.4
12.0
566
4092
K92.0
ICD-10 Finland
Haematemesis
2.0
12.0
146
729
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
11.9
856
6629
N05AN01
ATC
lithium; oral
2.0
11.9
150
758
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.5
11.9
436
3001
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
2.6
11.9
83
318
SPAT1104
SPAT
Monitoring of emergency patient
1.5
11.8
414
2824
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.3
11.8
105
454
5AB14
NOMESCO Finland
NA
7.9
11.8
26
33
N02AA01
ATC
morphine; systemic, rectal
2.6
11.8
86
337
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
7.0
11.8
28
40
L02BX03
ATC
abiraterone; oral
3.8
11.8
48
126
D07AB08
ATC
desonide; topical
1.4
11.8
655
4876
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
8.9
11.7
24
27
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
8.9
11.7
24
27
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
11.7
250
1508
L01BC59
ATC
trifluridine, combinations; systemic
7.3
11.7
27
37
JAL00
NOMESCO Finland
Biopsy of peritoneum
4.1
11.6
44
108
N03AX14
ATC
levetiracetam; systemic
1.9
11.6
165
876
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.1
11.6
134
654
JFB00
NOMESCO Finland
Partial resection of small intestine
2.2
11.6
113
515
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
18.9
11.6
17
9
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.3
11.5
106
467
E86
ICD-10 Finland
Volume depletion
2.0
11.5
141
708
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
11.5
302
1928
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
8.6
11.5
24
28
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.3
11.5
106
470
K02.1
ICD-10 Finland
Caries of dentine
1.2
11.5
3914
35783
2890X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Polycythaemia, secondary[ERYTHROCYTOSIS SECUNDARIA, NUD]
+∞
11.5
11
*
2898X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Other specified diseases of blood and blood-forming organs
+∞
11.5
11
*
N30.0
ICD-10 Finland
Acute cystitis
1.3
11.5
835
6481
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.6
11.4
311
2001
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
1.9
11.4
159
835
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
13.6
11.4
19
14
-44
ICPC
Preventive immunization/medic
1.4
11.4
514
3689
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.7
11.4
252
1537
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.6
11.4
259
1594
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.6
11.4
299
1909
J01FA10
ATC
azithromycin; systemic
1.2
11.3
4047
37122
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.1
11.3
123
587
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
7.8
11.3
25
32
R02
ICPC
Shortness of breath/dyspnoea
1.3
11.3
737
5631
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
35.0
11.3
14
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
10.5
11.2
21
20
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.5
11.2
84
336
E83.50
ICD-10 Finland
Hypercalcemia
2.4
11.2
90
373
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.1
11.2
125
605
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
7.2
11.2
26
36
KBV00
NOMESCO Finland
Insertion of stent into ureter
3.6
11.2
49
137
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
3.8
11.2
46
122
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
5.3
11.1
33
63
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
25.0
11.1
15
6
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
12.7
11.1
19
15
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
6.8
11.1
27
40
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
11.1
1822
15599
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.2
11.1
56
175
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.7
11.1
234
1411
N06AB04
ATC
citalopram; systemic
1.2
11.1
1364
11328
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
11.0
1794
15338
Z94.4
ICD-10 Finland
Liver transplant status
4.6
11.0
37
81
N05AB03
ATC
perphenazine; systemic, rectal
1.7
11.0
216
1273
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
3.7
11.0
47
129
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
3.7
11.0
47
129
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.4
11.0
88
365
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.7
10.9
70
256
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.4
10.9
87
358
X21
ICPC
Breast sympt/compl female other
2.1
10.9
117
554
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
10.9
522
3790
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.5
10.9
84
341
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.4
10.9
90
378
P72
ICPC
Schizophrenia
2.2
10.8
112
523
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.6
10.8
271
1707
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.6
10.8
263
1645
F20.1
ICD-10 Finland
Hebephrenic schizophrenia
7.8
10.8
24
31
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
7.8
10.8
24
31
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
15.5
10.8
17
11
S29
ICPC
Skin symptom/complaint other
1.3
10.8
1057
8540
1XX32
NOMESCO Finland
NA
8.2
10.8
23
28
B59
ICD-10 Finland
Pneumocystosis
10.5
10.7
20
19
GDG10
NOMESCO Finland
Bilateral transplantation of lung
8.8
10.7
22
25
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
2.0
10.7
128
637
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.4
10.7
502
3630
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
17.8
10.7
16
9
ZX110
NOMESCO Finland
Intracutaneous
6.1
10.7
28
46
WX400
NOMESCO Finland
Inhalation anesthesy
1.6
10.7
263
1650
D68.8
ICD-10 Finland
Other specified coagulation defects
2.7
10.7
72
271
JJC00
NOMESCO Finland
Allogenic transplantation of liver
5.8
10.7
29
50
SPAT1301
SPAT
No procedures
1.2
10.7
2131
18579
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
2.7
10.6
72
272
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
2.8
10.6
67
242
I50.0
ICD-10 Finland
Congestive heart failure
1.5
10.6
387
2662
1518
Kela drug reimbursment
NA
12.9
10.6
18
14
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
10.6
473
3385
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
10.6
577
4280
A07EC02
ATC
mesalazine; oral, rectal
1.5
10.6
326
2164
TJA10
NOMESCO Finland
Laparocentesis
5.1
10.6
32
63
XX1XN
NOMESCO Finland
Other isotope examination
2.8
10.6
64
227
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
4.1
10.6
40
99
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
3.2
10.5
54
171
E29.1
ICD-10 Finland
Testicular hypofunction
2.8
10.5
67
244
NF3AA
NOMESCO Finland
Femur X-ray examination
2.0
10.5
122
600
B02BX05
ATC
eltrombopag; oral
11.2
10.5
19
17
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
10.5
578
4293
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.6
10.5
258
1620
V03AG01
ATC
sodium cellulose phosphate; systemic
8.5
10.5
22
26
D69.1
ICD-10 Finland
Qualitative platelet defects
8.5
10.5
22
26
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.2
10.5
1222
10075
I50.1
ICD-10 Finland
Left ventricular failure
1.6
10.4
254
1589
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
10.4
1695
14482
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
110.1
10.4
11
*
9831/3-C42.1
ICD-O-3
T-cell large granular lymphocytic leukemia of bone marrow
110.1
10.4
11
*
D74.9
ICD-10 Finland
Methaemoglobinaemia, unspecified
+∞
10.4
10
*
D708
ICD-10 Finland
NA
+∞
10.4
10
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
4.4
10.4
36
82
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.3
10.4
51
157
SPAT1109
SPAT
Analgesia with portable analgesic pump
3.2
10.3
53
168
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
16.0
10.3
16
10
X58
ICD-10 Finland
Exposure to other specified factors
1.3
10.3
824
6477
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
32.5
10.3
13
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
3.8
10.3
42
111
E000006
ATC
NA
1.4
10.3
434
3073
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
10.3
204
1208
L02AE02
ATC
leuprorelin; implant, parenteral
1.6
10.3
257
1622
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.3
10.2
92
404
C01AA05
ATC
digoxin; systemic
1.4
10.2
436
3097
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
3.2
10.2
52
164
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.0
10.2
130
664
C08CA01
ATC
amlodipine; oral
1.2
10.2
2315
20406
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.9
10.1
153
833
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
6.2
10.1
26
42
R84
ICPC
Malignant neoplasm bronchus/lung
4.2
10.1
37
89
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.9
10.1
150
809
R03AK08
ATC
formoterol and beclometasone; inhalant
1.7
10.1
224
1371
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
10.1
271
1744
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.7
10.0
210
1263
SPAT1240
SPAT
Therapeutic discussion
1.4
10.0
593
4460
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.0
10.0
131
676
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.5
10.0
76
308
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
10.0
845
6699
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
40.1
10.0
12
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
5.1
10.0
30
59
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.5
9.9
320
2145
R13
ICD-10 Finland
Dysphagia
1.5
9.9
374
2591
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
3.6
9.9
43
120
RF210
NOMESCO Finland
NA
1.8
9.9
170
964
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
2.7
9.9
65
243
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.6
9.9
240
1504
153
Kela drug reimbursment
Lenalidomid
3.5
9.9
44
126
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.9
9.8
140
744
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
3.2
9.8
50
158
K12.10
ICD-10 Finland
Stomatitis NOS
3.6
9.8
43
121
A02BA02
ATC
ranitidine; systemic
1.2
9.8
1256
10459
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
26.0
9.8
13
5
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
9.8
271
1755
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
20.0
9.8
14
7
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
5.9
9.8
26
44
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.4
9.8
34
78
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.0
9.8
121
613
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.4
9.7
500
3673
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.8
9.7
172
986
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
1.9
9.7
133
699
WX730
NOMESCO Finland
Conventional respirator
2.1
9.7
104
496
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
6.5
9.7
24
37
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.1
9.7
101
475
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.7
9.7
196
1168
ZZA00
NOMESCO Finland
Split skin graft
1.7
9.7
175
1010
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.8
9.7
158
881
K83.0
ICD-10 Finland
Cholangitis
2.3
9.7
86
378
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
13.4
9.6
16
12
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.3
9.6
85
370
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.6
9.6
67
259
C07AB02
ATC
metoprolol; systemic
1.2
9.6
1278
10688
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
5.8
9.6
26
45
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.5
9.6
367
2550
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
3.2
9.6
48
150
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
9.6
1344
11304
J01FA09
ATC
clarithromycin; systemic
1.2
9.6
2065
18098
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.0
9.6
123
629
R55
ICD-10 Finland
Syncope and collapse
1.3
9.6
641
4916
WX610
NOMESCO Finland
Patient controlled analgesia
3.3
9.6
46
140
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.0
9.5
123
632
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
1.9
9.5
140
756
9109
FHL
Other measure in this category
6.3
9.5
24
38
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
5.0
9.5
29
58
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
9.5
896
7198
LCA06
NOMESCO Finland
Biopsy of endometrium
1.3
9.5
663
5114
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
3.1
9.5
49
157
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
9.5
479
3511
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
3.5
9.5
43
125
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
3.5
9.5
42
120
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.2
9.5
48
152
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.1
9.4
97
454
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
9.4
311
2100
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.0
9.4
54
183
N17.8
ICD-10 Finland
Other acute renal failure
2.5
9.4
72
293
R01AD12
ATC
fluticasone furoate; nasal
1.2
9.4
1829
15876
1BC01
NOMESCO Finland
NA
30.0
9.4
12
*
324
Kela drug reimbursment
Dasatinib
30.0
9.4
12
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
2.7
9.4
61
227
2899X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs
+∞
9.4
9
*
K12.18
ICD-10 Finland
Other forms of stomatitis
2.8
9.4
56
198
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
4.3
9.4
33
77
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
2.5
9.4
71
287
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
3.6
9.4
40
111
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.7
9.3
188
1121
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
12.3
9.3
16
13
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
12.3
9.3
16
13
D61.1
ICD-10 Finland
Drug-induced aplastic anaemia
21.7
9.3
13
6
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
1.9
9.3
130
688
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
5.5
9.3
26
47
A08
ICPC
Swelling
1.6
9.3
242
1542
M13.9
ICD-10 Finland
Arthritis, unspecified
1.4
9.3
422
3035
WF099
NOMESCO Finland
Other radiotherapy
3.2
9.3
46
143
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.6
9.3
258
1675
XQ800
NOMESCO Finland
Prick test
1.4
9.3
427
3077
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
2.2
9.3
93
430
H04.10
ICD-10 Finland
Dry eye syndrome
1.3
9.2
583
4433
P99
ICPC
Psychological disorders other
1.9
9.2
139
756
N06AB06
ATC
sertraline; oral
1.3
9.2
620
4756
A04
ICPC
Weakness/tiredness general
1.3
9.2
758
5982
J12.8
ICD-10 Finland
Other viral pneumonia
2.9
9.2
53
181
V03AE01
ATC
polystyrene sulfonate; oral
2.3
9.2
82
359
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.0
9.2
51
172
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
9.2
1514
12938
K74.3
ICD-10 Finland
Primary biliary cirrhosis
3.1
9.2
47
150
N06AX21
ATC
duloxetine; oral
1.3
9.2
637
4909
1CD01
NOMESCO Finland
NA
5.4
9.2
26
48
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
2.9
9.2
53
182
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
4.2
9.1
33
79
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.5
9.1
69
278
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.3
9.1
81
354
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.9
9.1
35
89
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.0
9.1
117
601
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
9.0
781
6204
C08CA05
ATC
nifedipine; systemic
1.4
9.0
378
2676
3028
Kela drug reimbursment
Mepolizumab
11.4
9.0
16
14
RF120
NOMESCO Finland
NA
2.3
9.0
78
336
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
2.3
9.0
81
356
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
4.6
9.0
30
66
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.5
9.0
69
280
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
2.9
9.0
53
185
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.1
9.0
97
465
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.3
9.0
81
357
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
5.6
9.0
25
45
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
9.0
300
2029
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
36.7
9.0
11
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
9.0
9.0
18
20
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
10.0
9.0
17
17
XG474
NOMESCO Finland
Exhalation nntrogen oxide
1.7
9.0
165
955
B81
ICPC
Anaemia vit B12/folate deficiency
1.6
9.0
221
1389
L04AX04
ATC
lenalidomide; oral
3.5
9.0
40
115
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.4
9.0
420
3035
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
9.0
1530
13111
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.9
9.0
35
90
E000003
ATC
NA
1.5
8.9
263
1731
SPAT1234
SPAT
Support of social functional capacity
1.5
8.9
287
1926
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
18.6
8.9
13
7
2AX05
NOMESCO Finland
NA
18.6
8.9
13
7
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
4.1
8.9
33
81
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
5.0
8.9
27
54
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
7.4
8.9
20
27
V03AC03
ATC
deferasirox; oral
24.0
8.9
12
5
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.3
8.9
650
5050
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.0
8.9
110
559
N19
ICD-10 Finland
Unspecified kidney failure
1.7
8.9
182
1093
9101
FHL
Bone biopsy
5.4
8.9
25
46
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.6
8.8
248
1612
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
2.9
8.8
52
182
HAD99
NOMESCO Finland
Other plastic operation on breast
3.0
8.8
49
166
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.0
8.8
49
166
N06AB10
ATC
escitalopram; oral
1.2
8.8
1174
9814
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.2
8.8
1006
8272
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.5
8.8
260
1715
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.4
8.8
394
2830
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
8.6
8.8
18
21
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
4.9
8.8
27
55
RS121
NOMESCO Finland
NA
3.1
8.8
46
150
A07EC01
ATC
sulfasalazine; oral, rectal
1.4
8.8
480
3568
XX4BW
NOMESCO Finland
NA
5.6
8.7
24
43
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
3.5
8.7
38
108
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.2
8.7
87
405
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
50.0
8.7
10
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
1.9
8.7
120
633
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
1.8
8.6
138
767
WX704
NOMESCO Finland
Intubation
1.4
8.6
419
3052
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
2.5
8.6
66
268
WW400
NOMESCO Finland
Plasmaferesis
5.2
8.6
25
48
A09AA02
ATC
multienzymes (lipase, protease etc.)
1.9
8.6
116
610
2951C
ICD-9 Finland
Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]
5.8
8.6
23
40
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
5.5
8.6
24
44
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.8
8.6
139
776
R03DX09
ATC
mepolizumab; parenteral
11.6
8.6
15
13
M05BA06
ATC
ibandronic acid; systemic
1.9
8.5
113
587
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
1.9
8.5
115
602
RD210
NOMESCO Finland
NA
1.9
8.5
119
631
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.3
8.5
628
4884
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
2.4
8.5
66
272
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
1.9
8.5
115
605
D72
ICD-10 Finland
Other disorders of white blood cells
27.5
8.5
11
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
1.9
8.5
117
620
2AA01
NOMESCO Finland
NA
20.0
8.5
12
6
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
20.0
8.5
12
6
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
2.7
8.5
56
212
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.0
8.4
97
478
M05.0
ICD-10 Finland
Felty syndrome
7.3
8.4
19
26
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
5.3
8.4
24
45
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
90.1
8.4
9
*
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
5.6
8.4
23
41
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
1.9
8.4
120
640
JFF10
NOMESCO Finland
Loop enterostomy
3.0
8.4
46
155
N06AA09
ATC
amitriptyline; systemic
1.3
8.4
611
4745
J01CA08
ATC
pivmecillinam; oral
1.2
8.4
2492
22372
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
8.4
1256
10628
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
8.4
69
294
L01XE08
ATC
[U] nilotinib; oral
12.7
8.4
14
11
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
7.8
8.3
18
23
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.6
8.3
59
232
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
4.8
8.3
26
54
D76.0
ICD-10 Finland
Langerhans' cell histiocytosis, not elsewhere classified
+∞
8.3
8
*
D76.2
ICD-10 Finland
Haemophagocytic syndrome, infection-associated
+∞
8.3
8
*
JM1AT
NOMESCO Finland
Cytology of spleen with ultrasound guidance
+∞
8.3
8
*
GDC00
NOMESCO Finland
Lobectomy of lung
3.0
8.3
46
156
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.4
8.3
68
288
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
3.3
8.3
40
123
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
2.6
8.3
58
226
N18.0
ICD-10 Finland
End-stage renal disease
2.3
8.3
71
308
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
3.7
8.3
34
92
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.0
8.3
105
539
R03BA05
ATC
fluticasone; inhalant
1.2
8.3
1112
9304
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.4
8.3
68
289
297
Kela drug reimbursment
NA
10.7
8.3
15
14
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.6
8.3
204
1288
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
4.6
8.3
27
59
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.3
8.3
488
3672
ZXC40
NOMESCO Finland
Use of ultrasound
2.7
8.3
53
196
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
2.2
8.2
81
373
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.4
8.2
65
271
A10AE05
ATC
insulin detemir; parenteral
1.5
8.2
312
2170
Z94.1
ICD-10 Finland
Heart transplant status
4.7
8.2
26
55
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
8.2
604
4697
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
3.3
8.2
39
119
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
14.5
8.2
13
9
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
14.5
8.2
13
9
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
14.5
8.2
13
9
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.7
8.2
152
885
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
2.5
8.2
58
229
306
Kela drug reimbursment
Erythropoietin and darbepoetin
4.2
8.2
29
69
I42.0
ICD-10 Finland
Dilated cardiomyopathy
1.7
8.1
150
872
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.1
8.1
3770
34917
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
4.1
8.1
30
74
N05AC02
ATC
thioridazine; oral
1.9
8.1
118
636
SPAT1290
SPAT
Preparation of deceased person
5.4
8.1
23
43
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
3.9
8.1
31
79
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.5
8.1
232
1521
175
Kela drug reimbursment
Deferasirox
33.4
8.1
10
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
17.2
8.1
12
7
ECB20
NOMESCO Finland
Oral alveoplasty
2.5
8.1
59
234
Z85.6
ICD-10 Finland
Personal history of leukaemia
11.7
8.1
14
12
R52.9
ICD-10 Finland
Pain, unspecified
1.3
8.0
486
3670
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
6.8
8.0
19
28
R33
ICD-10 Finland
Retention of urine
1.4
8.0
417
3075
JKA20
NOMESCO Finland
Cholecystectomy
1.7
8.0
151
886
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
4.4
8.0
27
61
L50.0
ICD-10 Finland
Allergic urticaria
1.7
8.0
142
818
WE100
NOMESCO Finland
Profylactic cytostatic therapy
10.0
8.0
15
15
-60
ICPC
Result test/procedure
1.4
8.0
343
2443
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
3.9
8.0
31
80
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.1
8.0
82
386
R2110
NOMESCO Finland
Giving the first information
1.4
8.0
395
2885
A91
ICPC
Abnormal result investigation NOS
1.5
8.0
243
1615
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.5
8.0
238
1573
F20
ICD-10 Finland
Schizophrenia
2.9
8.0
46
159
R5110
SPAT
NA
1.7
7.9
143
827
J01EA01
ATC
trimethoprim; systemic
1.2
7.9
1548
13418
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
7.2
7.9
18
25
SPAT1281
SPAT
Other administrative function
1.4
7.9
458
3433
WW200
SPAT
NA
0.7
7.9
356
4778
J04BA02
ATC
dapsone; oral
3.3
7.9
38
117
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
3.6
7.9
34
96
-1
NOMESCO Finland
NA
1.2
7.9
2114
18814
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
1.8
7.9
124
688
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
3.0
7.9
43
145
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
3.0
7.9
43
145
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
7.9
190
1193
L04AA10
ATC
sirolimus; oral
13.0
7.9
13
10
372
Kela drug reimbursment
Idelalisib
13.0
7.9
13
10
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.2
7.9
73
328
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
4.2
7.9
28
67
E87.5
ICD-10 Finland
Hyperkalaemia
2.0
7.8
93
467
J96.9
ICD-10 Finland
Respiratory failure, unspecified
3.1
7.8
40
129
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
1.8
7.8
129
726
C56
ICD-10 Finland
Malignant neoplasm of ovary
3.5
7.8
34
97
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
6.1
7.8
20
33
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
6.1
7.8
20
33
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
3.9
7.8
30
77
M54.5
ICD-10 Finland
Low back pain
1.2
7.8
2076
18464
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
3.8
7.8
31
82
XX9XW
NOMESCO Finland
NA
2.5
7.8
56
223
A12AA04
ATC
calcium carbonate; oral
2.0
7.8
94
472
K76.6
ICD-10 Finland
Portal hypertension
10.8
7.8
14
13
B82
ICPC
Anaemia other/unspecified
1.7
7.8
138
796
N05AL05
ATC
amisulpride; oral
9.4
7.8
15
16
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
9.4
7.8
15
16
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
3.4
7.7
35
103
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.1
7.7
85
413
N07BA03
ATC
varenicline; oral
1.5
7.7
271
1857
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
7.7
281
1939
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
45.0
7.7
9
*
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
3.0
7.7
42
142
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
2.6
7.7
54
212
K72.9
ICD-10 Finland
Hepatic failure, unspecified
3.2
7.7
38
120
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
2.5
7.7
55
219
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
2.6
7.7
53
204
QBA00
NOMESCO Finland
Puncture of skin of trunk
3.4
7.7
35
104
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.3
7.6
570
4442
L95.8
ICD-10 Finland
Other vasculitis limited to skin
3.9
7.6
29
74
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.5
7.6
214
1395
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
2.3
7.6
64
277
L01XX17
ATC
[U] topotecan; systemic
18.3
7.6
11
6
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
18.3
7.6
11
6
L01EA03
ATC
nilotinib; oral
18.3
7.6
11
6
C92.7
ICD-10 Finland
Other myeloid leukaemia
18.3
7.6
11
6
S94
ICPC
Ingrowing nail
2.0
7.6
89
446
D46
ICD-10 Finland
Myelodysplastic syndromes
25.0
7.6
10
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
3.1
7.6
39
127
R03DC03
ATC
montelukast; oral
1.2
7.6
946
7852
T81.9
ICD-10 Finland
Unspecified complication of procedure
1.9
7.6
105
557
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.3
7.5
530
4096
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
7.5
236
1582
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.4
7.5
351
2546
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.3
7.5
65
284
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
3.4
7.5
34
101
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
2.8
7.5
45
162
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.5
7.5
272
1879
-69
ICPC
Other reason for encounter NEC
1.5
7.4
226
1502
PG1UT
NOMESCO Finland
Percutaneous aspiration throbectomy
4.0
7.4
28
71
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
1.6
7.4
161
986
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
3.6
7.4
31
86
C94.7
ICD-10 Finland
Other specified leukaemias
80.1
7.4
8
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
3.3
7.4
35
107
J01XX08
ATC
linezolid; systemic
3.0
7.4
39
129
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
2.7
7.4
48
180
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.6
7.4
49
187
R81
ICPC
Pneumonia
1.6
7.4
183
1158
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
7.6
7.4
16
21
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
3.2
7.4
36
113
N02AA03
ATC
hydromorphone; systemic, rectal
4.0
7.3
27
67
SAA02
NOMESCO Finland
Basic examination of mouth
1.1
7.3
4471
42045
J01CF05
ATC
flucloxacillin; systemic
1.5
7.3
211
1387
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
2.6
7.3
51
198
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
2.8
7.3
43
152
H26.3
ICD-10 Finland
Drug-induced cataract
2.8
7.3
43
152
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
2.8
7.3
43
152
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
2.9
7.3
40
136
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
4.3
7.3
25
58
Z31.6
ICD-10 Finland
General counselling and advice on procreation
2.6
7.3
48
182
WVA20
NOMESCO Finland
Medicine administration
1.7
7.3
128
736
-51
ICPC
I&d/flush/aspiration
2.2
7.3
69
313
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
7.3
1856
16437
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
7.3
3956
36922
TQB05
NOMESCO Finland
Puncture of skin of trunk
2.4
7.3
59
251
AA1AA
NOMESCO Finland
Head X-ray examination
2.5
7.3
55
225
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
3.4
7.3
33
98
C95.9
ICD-10 Finland
Leukaemia, unspecified
9.3
7.3
14
15
E000002
ATC
NA
1.3
7.3
649
5182
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
2.2
7.3
69
315
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
7.3
349
2542
K50.8
ICD-10 Finland
Other Crohn disease
2.0
7.3
90
458
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
3.2
7.2
35
109
M35.1
ICD-10 Finland
Other overlap syndromes
3.1
7.2
37
120
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
2.5
7.2
54
218
R05
ICPC
Cough
1.2
7.2
1353
11680
328
Kela drug reimbursment
Nilotinib
15.7
7.2
11
7
L01XX47
ATC
[U] idelalisib; oral
15.7
7.2
11
7
K76.9
ICD-10 Finland
Liver disease, unspecified
2.0
7.2
81
398
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
7.2
407
3044
JFB30
NOMESCO Finland
Right hemicolectomy
2.0
7.2
83
411
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
1.8
7.2
116
650
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
2.4
7.2
58
246
X77
ICPC
Malignant neopl genital female other
4.2
7.2
25
59
K30
ICD-10 Finland
Functional dyspepsia
1.3
7.2
593
4684
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
7.3
7.2
16
22
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.2
158
971
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
30.0
7.1
9
*
1DB06
NOMESCO Finland
NA
30.0
7.1
9
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.1
7.1
78
378
TGA30
NOMESCO Finland
Thoracocentesis
2.5
7.1
51
203
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.6
7.1
179
1137
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
1.9
7.1
100
535
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
3.2
7.1
34
105
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
1.7
7.1
137
808
TFP20
NOMESCO Finland
Cardiodefibrillation
1.3
7.1
419
3152
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.8
7.1
28
74
R16.2
ICD-10 Finland
Hepatomegaly with splenomegaly, not elsewhere classified
20.0
7.1
10
5
F20.0
ICD-10 Finland
Paranoid schizophrenia
2.6
7.1
50
196
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
7.1
399
2985
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
7.9
7.1
15
19
L95
ICPC
Osteoporosis
1.6
7.1
164
1022
K05.31
ICD-10 Finland
Periodontitis pronounced
1.3
7.1
564
4438
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
2.5
7.1
50
197
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
1.9
7.1
91
471
SPAT1325
SPAT
Vaccination
1.1
7.1
2279
20534
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.3
7.1
60
261
B18.2
ICD-10 Finland
Chronic viral hepatitis C
2.3
7.1
63
281
N06DX01
ATC
memantine; oral
0.6
7.1
129
2032
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
6.0
7.1
18
30
R4180
NOMESCO Finland
Podiatric therapy
2.2
7.1
65
293
315
Kela drug reimbursment
Clopidogrel
2.2
7.1
65
293
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.2
7.1
34
106
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
5.6
7.0
19
34
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
3.0
7.0
37
123
R01AD08
ATC
fluticasone; nasal
1.2
7.0
1782
15774
D01
ICPC
Abdominal pain/cramps general
1.3
7.0
588
4660
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.5
7.0
204
1347
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.0
7.0
82
412
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
1.8
7.0
112
627
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
1.7
7.0
146
886
A12BA01
ATC
potassium chloride; oral
1.5
7.0
235
1599
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.3
6.9
555
4366
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
3.0
6.9
37
124
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
3.9
6.9
26
66
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
2.8
6.9
41
146
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
6.9
261
1817
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.6
6.9
151
927
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
5.1
6.9
20
39
369
Kela drug reimbursment
Regorafenib
5.1
6.9
20
39
SPAT1291
SPAT
Other function in accordance with NCSP classification
1.9
6.9
94
498
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
2.8
6.9
42
153
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
2.9
6.9
40
140
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
2.9
6.9
40
140
ZX197
NOMESCO Finland
NA
7.5
6.9
15
20
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
6.9
555
4375
Z51.88
ICD-10 Finland
Other specified medical care
1.8
6.9
106
588
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
6.9
240
1648
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.6
6.9
155
960
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
2.3
6.9
58
251
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
3.2
6.9
33
103
IEV99
NOMESCO Finland
Other psychiatric network intervention
3.2
6.9
33
103
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
4.0
6.9
25
62
QDA10
NOMESCO Finland
Incision of skin of lower limb
2.6
6.9
48
187
WX723
NOMESCO Finland
CPAP therapy
1.5
6.8
190
1238
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
3.9
6.8
26
67
K56.7
ICD-10 Finland
Ileus, unspecified
1.9
6.8
89
464
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.8
6.8
101
550
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.8
6.8
40
142
JJ5AT
NOMESCO Finland
NA
6.7
6.8
16
24
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.4
6.8
287
2043
KAS40
NOMESCO Finland
Excision of transplanted kidney
9.3
6.8
13
14
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
6.8
529
4151
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
6.1
6.8
17
28
A01
ICPC
Pain general/multiple sites
1.3
6.7
427
3255
352
Kela drug reimbursment
Abiraterone and enzalutamide
2.7
6.7
42
156
UJK02
NOMESCO Finland
ERCP
1.7
6.7
135
809
J45.8
ICD-10 Finland
Mixed asthma
1.6
6.7
170
1086
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.3
6.7
57
247
N05AE04
ATC
ziprasidone; systemic
2.7
6.7
41
150
K59.0
ICD-10 Finland
Constipation
1.4
6.7
307
2217
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
1.9
6.7
88
459
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
1.8
6.7
100
545
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.6
6.7
147
905
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
3.0
6.7
35
116
ZX050
NOMESCO Finland
Stereotactic radiotherapy
2.5
6.7
48
192
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
4.7
6.7
21
45
XG405
NOMESCO Finland
Education on PEF monitoring
1.9
6.7
86
447
B07.9
ICD-10 Finland
Verruca simplex
1.5
6.7
185
1205
C07AA05
ATC
propranolol; systemic
1.2
6.7
1133
9690
GD6AD
NOMESCO Finland
CT of chest and neck
4.1
6.7
24
59
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
1.8
6.7
98
534
134
Kela drug reimbursment
General erythroderma
3.2
6.7
32
100
F20.5
ICD-10 Finland
Residual schizophrenia
2.7
6.7
41
151
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.4
6.7
54
230
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.7
6.6
136
820
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
3.9
6.6
25
64
NXL00
NOMESCO Finland
Biopsy of muscle
3.7
6.6
27
74
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
3.0
6.6
35
117
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.8
6.6
111
631
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.5
6.6
207
1387
P28
ICPC
Limited function/disability (P)
2.5
6.6
50
204
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
6.6
1735
15392
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
5.5
6.6
18
33
HAD40
NOMESCO Finland
Mastopexy
2.7
6.6
40
146
RS140
NOMESCO Finland
NA
4.2
6.6
23
55
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.6
6.6
162
1027
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.6
6.6
152
946
G04CA02
ATC
tamsulosin; oral
1.2
6.6
1293
11204
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
12.2
6.6
11
9
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
1.6
6.6
142
870
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
3.2
6.5
31
96
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
3.6
6.5
27
75
T80.2
ICD-10 Finland
Infections following infusion, transfusion and therapeutic injection
8.7
6.5
13
15
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
8.7
6.5
13
15
SPAT1139
SPAT
Nutrition survey
1.5
6.5
182
1190
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.6
6.5
46
180
3039
Kela drug reimbursment
NA
10.0
6.5
12
12
1517
Kela drug reimbursment
NA
10.0
6.5
12
12
156
Kela drug reimbursment
Lapatinib
10.0
6.5
12
12
M05BB03
ATC
alendronic acid and colecalciferol; oral
1.7
6.5
123
727
GD1LA
NOMESCO Finland
GD
2.0
6.5
78
394
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.5
138
839
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.4
6.5
53
226
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
3.3
6.5
30
91
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
2.5
6.5
48
196
K51.5
ICD-10 Finland
Left sided colitis
1.6
6.5
143
882
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
1.8
6.5
110
630
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
6.5
1139
9774
K83.1
ICD-10 Finland
Obstruction of bile duct
2.1
6.5
71
347
GD2SN
NOMESCO Finland
Lung ventilation SPECT
2.6
6.5
44
172
329
Kela drug reimbursment
Lenalidomide
3.5
6.5
28
81
D11
ICPC
Diarrhoea
1.3
6.5
583
4661
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
5.3
6.4
18
34
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
2.9
6.4
37
128
5AD01
NOMESCO Finland
NA
69.9
6.4
7
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
69.9
6.4
7
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
69.9
6.4
7
*
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
1.8
6.4
98
542
B02AA02
ATC
tranexamic acid; systemic
1.2
6.4
837
6979
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.5
6.4
194
1290
A41.4
ICD-10 Finland
Sepsis due to anaerobes
4.2
6.4
22
52
GBB00
NOMESCO Finland
Tracheostomy
2.2
6.4
63
294
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
14.3
6.4
10
7
C91
ICD-10 Finland
Lymphoid leukaemia
14.3
6.4
10
7
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
3.2
6.4
31
98
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.4
6.4
238
1658
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
1.7
6.3
114
663
XQ902
NOMESCO Finland
Other photography
2.7
6.3
39
144
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
2.6
6.3
43
168
-56
ICPC
Dressing/pressure/compress/tamponade
1.8
6.3
95
521
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
1.8
6.3
108
617
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
2.2
6.3
57
255
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
2.2
6.3
57
255
N62
ICD-10 Finland
Hypertrophy of breast
1.5
6.3
208
1412
F20.19
ICD-10 Finland
Hebefren schizophrenia UNS
5.1
6.3
18
35
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
6.3
159
1017
ZXY49
NOMESCO Finland
Other health care provider
3.1
6.3
32
105
1XC07
NOMESCO Finland
NA
3.8
6.2
24
63
2888X
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOPATHIA ALIA DEFINITA]
+∞
6.2
6
*
9975/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, unclassifiable of bone marrow
+∞
6.2
6
*
2880A
ICD-9 Finland
Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, IDIOPATHICA]
+∞
6.2
6
*
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
6.2
6
*
JMA00
NOMESCO Finland
Partial splenectomy
+∞
6.2
6
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
6.2
6
*
2880X
ICD-9 Finland
Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, NUD]
+∞
6.2
6
*
N63
ICD-10 Finland
Unspecified lump in breast
1.4
6.2
307
2246
L50.9
ICD-10 Finland
Urticaria, unspecified
1.5
6.2
186
1233
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.9
6.2
36
126
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
26.7
6.2
8
*
J05AX18
ATC
letermovir; oral
26.7
6.2
8
*
C84.1
ICD-10 Finland
Sézary disease
26.7
6.2
8
*
Q21.81
ICD-10 Finland
Eisenmenger's syndrome
26.7
6.2
8
*
J02AC05
ATC
isavuconazole; systemic
26.7
6.2
8
*
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
26.7
6.2
8
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.4
6.2
274
1969
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
4.8
6.2
19
40
H53.1
ICD-10 Finland
Subjective visual disturbances
1.3
6.2
348
2606
M01AH02
ATC
rofecoxib; oral
1.2
6.2
785
6526
J46
ICD-10 Finland
Status asthmaticus
1.6
6.2
145
909
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.7
6.2
125
754
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
1.9
6.2
84
446
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.4
6.2
283
2045
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
6.2
1129
9721
M05BA07
ATC
risedronic acid; oral
1.6
6.2
164
1062
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
3.6
6.2
25
69
K86.3
ICD-10 Finland
Pseudocyst of pancreas
2.8
6.1
36
128
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.6
6.1
138
857
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
4.5
6.1
20
45
R95
ICPC
Chron obstructive pulmonary disease
1.6
6.1
136
841
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
6.1
4893
46528
L04AX02
ATC
thalidomide; oral
7.7
6.1
13
17
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
7.7
6.1
13
17
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
2.2
6.1
54
242
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.2
6.1
798
6658
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
1.8
6.1
95
529
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
12.5
6.1
10
8
N91.1
ICD-10 Finland
Secondary amenorrhoea
2.0
6.1
68
336
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
3.8
6.1
23
60
XF612
NOMESCO Finland
Measurement of central venous pressure
3.8
6.1
23
60
A10BB12
ATC
glimepiride; oral
1.3
6.1
373
2831
XQ848
NOMESCO Finland
Dermatological photography
1.6
6.0
137
853
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
8.6
6.0
12
14
A49.0
ICD-10 Finland
Staphylococcal infection, unspecified site
3.3
6.0
28
86
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.3
6.0
374
2843
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
2.6
6.0
40
154
6753
FHL
Transabdominal splenectomy
6.7
6.0
14
21
N99.0
ICD-10 Finland
Postprocedural renal failure
6.7
6.0
14
21
ZSZ10
NOMESCO Finland
Secondary repair operation
6.7
6.0
14
21
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.5
6.0
203
1387
J86.9
ICD-10 Finland
Pyothorax without fistula
2.4
6.0
47
198
Z50.1
ICD-10 Finland
Other physical therapy
1.4
6.0
305
2248
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016228) CD19 cells/100 cells in Blood
323
270
12.35
323.31
2.5
1.9
%
7.6
7.9
0.08
316
260
(21494814) CD8 cells/100 lymphocytes in Specimen
317
260
12.58
320.92
2.5
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2018
8500
2.75
314.77
2.4
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2017
8508
2.74
313.62
2.5
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1493
5360
3.12
312.01
1.5
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
413
510
8.42
311.78
3.4
2.5
e6/l
835.3
692.3
0.19
154
211
(3017143) Hepatitis C virus Ab [Presence] in Serum
1981
8328
2.75
309.68
1.7
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
282
202
14.36
309.31
2.4
1.9
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
411
511
8.36
308.51
3.3
2.5
e6/l
644.0
503.5
0.81
333
428
(21494434) Karyotype in Bone marrow
891
518
18.89
307.65
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
2081
5785
4.33
307.65
4.2
2.7
g/l
9.8
10.6
9.78
1934
5296
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6173
39219
2.66
307.65
12.3
6.6
mmol/l
1.2
1.2
0.36
4969
33154
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
905
718
13.84
307.65
1.1
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
949
2202
4.68
307.65
3.7
2.8
g/l
3.4
3.6
4.70
913
2092
(3002030) Lymphocytes/100 leukocytes in Blood
6960
37743
4.22
307.65
13.7
6.0
%
29.8
27.9
21.38
6687
35048
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
930
1752
5.78
307.65
2.4
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
3714
8554
6.51
307.65
8.2
3.9
u/l
258.2
240.9
6.57
3576
8048
(3000093) Morphology [Interpretation] in Blood Narrative
497
696
7.48
307.65
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
659
691
10.18
307.65
3.1
2.4
e9/l
1.1
1.1
0.00
450
407
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
776
1250
6.67
307.65
2.5
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1554
5263
3.34
307.65
2.9
2.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
641
974
6.99
307.65
2.0
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
674
1332
5.37
307.65
1.5
1.4
u/ml
104.9
116.9
1.45
141
282
(3023520) Reticulocytes [#/volume] in Blood
2524
6364
5.05
307.65
4.7
2.4
e9/l
72.4
69.3
2.89
1964
4780
(3008757) Leukocyte morphology finding [Identifier] in Blood
523
804
6.83
307.65
6.9
3.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
886
1692
5.68
307.65
1.9
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2918
12708
2.88
307.65
7.2
3.3
mmol/l
0.8
0.8
10.98
2804
11848
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2770
12444
2.74
307.65
2.7
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
4479
20907
3.17
307.65
7.8
4.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1004
1451
7.62
307.65
7.7
5.3
iu/ml
2025.2
1491.0
0.12
142
209
(4035726)
1925
6930
3.23
307.65
1.6
1.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
550
547
10.62
307.65
2.6
2.1
%
72.4
72.1
0.12
529
519
(3018010) Neutrophils/100 leukocytes in Blood
6781
37225
3.92
307.65
12.7
5.8
%
54.1
57.3
52.35
6502
34702
(40760892) CBC W Ordered Manual Differential panel - Blood
3527
16913
2.73
307.65
9.6
4.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
1693
4485
4.38
307.65
2.4
1.8
g/l
1.3
1.4
0.52
1555
4097
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
551
801
7.24
307.65
2.1
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
6919
36784
4.31
307.65
14.1
6.2
%
9.2
8.6
20.15
6664
34347
(3042111) Morphology [Interpretation] in Bone marrow Narrative
1486
1073
16.25
307.65
1.9
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2697
11294
2.94
307.65
2.9
2.5
g/l
2.3
2.3
3.81
2541
10451
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2348
10171
2.74
307.65
9.0
5.8
mmol/l
1.0
1.0
0.44
2246
9458
(3002179) Metamyelocytes/100 leukocytes in Blood
2137
5874
4.41
307.65
7.2
3.7
%
0.8
0.6
3.37
1014
1248
(3004809) Band form neutrophils/100 leukocytes in Blood
874
1196
7.95
307.65
5.4
3.1
%
1.5
1.4
0.28
736
915
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
542
535
10.69
307.65
2.6
2.1
%
11.4
14.8
3.90
220
261
(3024561) Albumin [Mass/volume] in Serum or Plasma
5414
33930
2.40
307.65
8.3
4.8
g/l
34.1
35.5
53.03
5117
31457
(3001604) Monocytes [#/volume] in Blood
6915
39115
3.88
307.65
12.4
5.7
e9/l
0.6
0.6
2.26
6333
33516
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1183
3459
3.77
307.65
2.2
1.6
g/l
1.4
1.6
8.01
1007
2950
(3010503) CD19 cells [#/volume] in Blood
434
416
10.89
307.65
3.2
2.4
e9/l
0.5
0.2
0.73
422
400
(3006315) Basophils [#/volume] in Blood
6951
39288
3.92
307.65
12.4
5.7
e9/l
0.0
0.0
1.63
6365
33665
(3019198) Lymphocytes [#/volume] in Blood
6996
40216
3.86
307.65
12.6
5.8
e9/l
2.5
1.9
8.61
6500
35157
(3006504) Eosinophils/100 leukocytes in Blood
6875
36586
4.24
307.65
13.4
5.9
%
2.8
2.9
2.35
6614
34001
(3025159) Blasts/100 leukocytes in Blood
2010
5792
4.14
307.65
7.6
4.0
%
0.3
0.4
0.26
1076
1342
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1562
5540
3.18
307.65
2.3
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
5812
26729
4.06
307.65
12.8
5.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
590
574
10.90
307.65
2.7
2.3
%
34.5
43.3
2.65
61
73
(3018418) pH of Serum or Plasma
4318
23121
2.60
307.65
7.9
3.9
ph
7.4
7.4
0.40
1224
4361
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
6816
40617
3.44
307.65
13.8
6.0
umol/l
11.2
11.5
1.08
6629
38484
(3022948) Iron [Moles/volume] in Serum or Plasma
2787
12216
2.82
307.65
3.0
2.5
umol/l
13.4
13.0
1.92
2634
11311
(3021589) Normoblasts [#/volume] in Blood
5557
34558
2.48
307.65
21.3
9.4
e9/l
0.0
0.0
4.53
4826
28016
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
534
502
11.22
307.65
2.6
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2612
10511
3.05
307.65
3.0
2.6
%
24.4
22.4
7.83
2328
8942
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
908
1702
5.80
307.65
2.6
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
7586
45306
4.44
307.65
24.8
8.7
e9/l
3.8
4.1
11.25
7117
39325
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
727
1479
5.24
307.65
1.5
1.4
u/ml
21.5
18.6
—
6
30
(3017181) Myelocytes/100 leukocytes in Blood
2400
6438
4.66
307.65
7.4
3.9
%
1.2
0.9
4.82
1349
1720
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
1074
1068
11.22
307.65
1.4
1.2
u/l
43.7
34.0
0.89
947
931
(3021440) Promyelocytes/100 leukocytes in Blood
2205
6143
4.38
307.65
7.4
3.9
%
0.2
0.1
1.02
1258
1602
(3045142) Bone marrow Pathology biopsy report
1251
653
21.93
307.65
1.5
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5730
35578
2.56
307.65
10.8
6.0
mmol/l
1.2
1.2
0.11
5383
32217
(3013115) Eosinophils [#/volume] in Blood
7054
40549
3.93
307.65
13.7
5.9
e9/l
0.2
0.2
0.13
6504
35355
(3020630) Protein [Mass/volume] in Serum or Plasma
1777
6396
3.19
307.65
3.2
2.5
g/l
65.6
66.4
3.58
1657
5809
(3022096) Basophils/100 leukocytes in Blood
6770
35490
4.21
307.65
13.3
5.9
%
0.7
0.7
6.55
6520
33009
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
8008
60396
3.16
307.65
17.8
7.4
u/l
84.3
78.6
18.26
7796
56835
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
733
1481
5.28
307.65
1.5
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
3106
8533
4.94
307.65
4.5
2.4
%
1.8
1.8
0.45
2849
7513
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
815
1112
7.93
307.65
3.9
2.8
u/ml
20320.5
1936.4
1.07
75
63
(3026493) Urate [Moles/volume] in Serum or Plasma
3667
20536
2.29
306.01
4.9
2.6
umol/l
1958.2
4412.3
5.85
3344
17704
(40758558) Short blood count panel - Blood
3575
19982
2.27
297.92
18.3
6.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
388
493
8.16
285.89
3.5
2.6
e9/l
0.2
0.2
1.74
329
426
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
671
1468
4.84
285.87
1.3
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
399
525
7.89
285.43
1.5
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
617
1301
5.00
274.47
1.8
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
540
1015
5.58
273.54
1.8
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
2899
15358
2.28
269.61
3.5
2.8
mosm/kgh2o
523.9
546.2
6.73
2589
13055
(46235355) HIV 1 and 2 tests - Meaningful Use set
2469
12323
2.36
263.22
1.8
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
3930
23804
2.12
258.00
4.3
3.3
e6/l
92.3
85.5
0.10
3283
18220
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
2178
10368
2.43
257.77
1.7
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
304
324
9.66
257.20
5.1
3.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
800
2182
3.91
254.91
1.4
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
4827
31706
2.07
253.11
11.3
9.0
inr
1.2
1.3
2.10
1798
8956
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
614
1386
4.67
251.24
1.4
1.3
u/ml
265.7
273.2
0.25
409
839
(3000850) Epithelial cells [#/volume] in Urine
2999
16586
2.18
246.94
3.4
2.6
e6/l
5.9
5.4
0.82
2713
14509
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
816
2360
3.69
238.41
3.5
3.1
ratio
3.3
2.2
0.37
58
189
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
951
3053
3.35
236.38
2.6
1.9
ug/l
1.7
2.3
0.88
883
2691
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
293
333
9.05
235.98
2.1
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
826
2425
3.64
235.93
3.6
3.2
mg/l
37.6
48.7
1.03
655
1973
(3034860) Kappa light chains.free [Mass/volume] in Serum
826
2425
3.64
235.93
3.6
3.2
mg/l
56.5
78.7
0.43
653
1970
(3013826) Glucose [Moles/volume] in Serum or Plasma
6275
46019
2.09
235.74
8.1
4.6
mmol/l
6.7
6.7
0.12
6040
42997
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
292
333
9.02
234.54
2.1
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2370
12143
2.27
233.70
3.5
2.1
s
30.3
29.9
2.81
2312
11785
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
366
555
6.82
230.13
1.8
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
808
2381
3.62
229.32
4.0
2.5
%
89.8
91.3
0.97
752
2240
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1517
6415
2.63
228.51
7.3
3.7
mmol/l
1.2
1.2
2.52
1401
5605
(3030467) Casts [#/volume] in Urine by Automated count
3598
21866
2.04
226.51
4.2
3.2
e6/l
0.4
0.4
0.08
2973
16417
(36304419) Bacteria [Presence] in Urine
3520
21260
2.05
225.10
4.0
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
2180
10984
2.28
222.36
2.3
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1892
9008
2.38
220.03
5.2
2.7
umol/l
9.4
8.3
1.01
1684
7815
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3306
19649
2.05
219.85
2.7
2.3
mg/l
3.4
2.9
14.24
2884
16783
(3018095) Leukocytes [#/volume] in Urine
4254
27759
1.97
215.71
5.0
3.7
e6/l
105.9
98.1
0.19
3403
19631
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
356
561
6.56
215.67
2.0
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
514
1139
4.71
214.69
1.8
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
477
995
5.00
214.21
1.8
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4826
33002
1.95
211.71
4.1
2.8
ug/l
261.6
129.0
21.88
4510
30481
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
363
595
6.30
211.55
1.7
1.8
mg/l
4.0
4.1
0.14
339
571
(3015377) Calcium [Moles/volume] in Serum or Plasma
4082
26455
1.96
209.32
6.0
3.3
mmol/l
2.3
2.4
11.54
3724
22961
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
419
799
5.44
208.34
2.7
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
2663
14940
2.09
204.38
2.1
1.5
g/l
2.2
2.4
6.17
1941
8901
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
798
2518
3.37
202.97
3.4
2.3
g/l
1.3
0.9
1.65
705
2158
(3033658) Prothrombin time (PT) actual/Normal
3290
20138
1.97
196.36
7.3
4.0
%
87.5
89.9
6.32
3198
19655
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
389
732
5.50
196.18
2.8
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
652
1845
3.72
195.85
3.3
3.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
877
2993
3.13
195.70
3.1
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
876
2989
3.13
195.54
3.1
2.2
g/l
3.7
3.8
0.94
664
2115
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
877
2995
3.13
195.47
3.1
2.2
g/l
7.1
7.4
5.25
677
2219
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3900
25343
1.92
194.23
5.6
3.2
u/l
36.8
34.9
0.74
3745
23977
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
837
2794
3.19
193.86
3.2
2.2
g/l
3.2
3.1
2.05
665
2163
(3017354) Segmented neutrophils/100 leukocytes in Blood
397
770
5.34
193.60
6.0
3.1
%
51.3
58.9
5.92
256
499
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
725
2221
3.45
193.00
3.2
2.2
g/l
0.1
0.0
0.27
670
2024
(3037756) Immunofixation for Serum or Plasma
593
1588
3.92
192.81
1.7
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
137
59
23.55
190.74
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
385
739
5.39
189.91
1.4
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
283
401
7.24
189.25
3.3
2.5
%
38.8
38.3
0.10
83
143
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
591
1613
3.84
186.94
1.7
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
369
697
5.47
185.25
1.3
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
238
284
8.57
184.27
2.6
2.3
%
31.6
27.9
2.20
224
266
(44790048)
404
831
5.03
184.16
2.1
1.5
—
—
—
0
0
(44806118)
404
831
5.03
184.16
2.1
1.5
—
—
—
0
0
(44790047)
404
831
5.03
184.16
2.1
1.5
—
—
—
0
0
(44790049)
404
831
5.03
184.16
2.1
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
377
732
5.32
183.56
2.5
2.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1533
7167
2.36
182.83
2.6
2.2
nmol/l
363.2
373.9
1.11
1454
6582
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
815
2781
3.11
181.49
3.1
2.2
g/l
10.5
10.2
0.52
700
2332
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
293
457
6.58
179.11
1.9
1.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
237
292
8.30
178.76
2.8
2.5
%
12.9
11.2
0.64
216
270
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
672
2059
3.44
178.53
3.2
2.2
g/l
0.0
0.0
0.36
617
1868
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
127
54
23.82
177.65
2.3
4.3
mg/l
1.4
1.6
0.13
81
40
(40765096) Chromosome analysis panel by Banding
200
200
10.19
177.04
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1634
7983
2.27
175.10
5.3
3.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
675
2100
3.38
174.97
6.4
4.2
mg/l
1.5
1.5
0.26
629
1934
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
159
113
14.29
174.86
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
1413
6508
2.38
173.70
5.0
4.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
658
2024
3.42
173.64
3.2
2.2
g/l
0.0
0.0
0.00
617
1861
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
269
398
6.93
172.84
2.0
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
711
2303
3.26
172.60
3.1
2.1
g/l
37.6
37.7
0.08
637
1971
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
269
403
6.84
170.83
2.0
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1544
7453
2.28
169.87
2.7
2.3
g/l
0.2
0.2
4.31
1428
6942
(3048879) Bone marrow aspiration report
193
195
10.08
169.57
2.4
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1473
7000
2.31
168.04
11.2
7.4
mmol/l
9.8
9.8
0.03
1411
6686
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
684
2212
3.26
166.34
1.7
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3711
24655
1.83
164.79
3.4
2.6
u/l
53.6
58.1
8.46
3482
22717
(3000060) B lymphocytes [#/volume] in Blood
195
209
9.51
164.05
2.8
2.6
e6/l
1427.4
213.8
1.09
117
120
(3044640) Blood type and Crossmatch panel - Blood
3729
24936
1.82
161.10
4.9
2.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
669
2178
3.23
160.79
3.8
2.7
%
197.3
193.0
0.56
642
2074
(3031040) Bacteria [#/volume] in Urine by Automated count
6516
51461
1.86
160.64
5.8
4.5
e6/l
736.1
1629.7
1.27
149
706
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
748
2610
3.03
159.65
2.6
2.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
356
746
4.92
158.61
1.4
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1936
10545
2.05
154.99
1.5
1.3
titre
607.1
527.9
0.90
429
2206
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
101
37
27.58
149.00
5.4
4.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
4958
36658
1.74
146.82
7.3
4.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
561
1745
3.35
144.95
5.2
4.1
mmol/l
2.5
2.5
0.09
405
1181
(3009445) Proteinase 3 Ab [Units/volume] in Serum
857
3383
2.69
144.85
1.5
1.6
u/ml
10.6
17.1
0.78
18
95
(3013290) Carbon dioxide [Partial pressure] in Blood
561
1746
3.35
144.82
5.2
4.1
kpa
5.0
5.0
0.07
548
1713
(3027315) Oxygen [Partial pressure] in Blood
563
1758
3.34
144.56
5.2
4.2
kpa
8.5
8.6
0.84
550
1724
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2731
17059
1.85
143.81
2.5
1.8
mg/l
1.6
1.2
4.73
2160
13012
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
658
2275
3.03
142.33
1.8
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
7068
58142
1.86
142.22
6.3
4.1
mm/h
15.4
12.2
38.03
6657
53775
(3037467) Urinalysis macro (dipstick) panel - Urine
6654
53796
1.80
141.10
5.7
4.3
—
—
—
0
0
(3036489) Thrombin time
765
2894
2.79
140.31
3.5
2.2
s
22.0
21.5
1.49
700
2524
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1574
8270
2.08
137.27
4.8
4.1
ug/l
25.7
28.3
0.13
1290
6705
(3000012) Reticulocyte production index
236
387
6.23
137.23
1.9
1.3
—
—
—
0
0
(3010421) pH of Blood
604
2036
3.10
136.42
5.2
4.1
ph
7.4
7.4
1.41
548
1715
(1616796) Gas panel - Central venous blood
543
1730
3.27
134.80
4.5
3.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
303
637
4.88
134.37
3.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
303
637
4.88
134.37
3.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
303
637
4.88
134.37
3.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
143
132
10.98
133.75
3.3
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1070
4932
2.32
128.98
10.2
7.6
mmol/l
24.9
24.8
0.34
1056
4900
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
592
2054
3.01
126.98
2.0
2.0
mg/l
12.2
11.1
0.95
544
1900
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
696
2655
2.75
125.25
1.8
1.6
titre
354.7
259.7
0.27
29
110
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
111
76
14.77
124.53
1.3
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1653
9227
1.96
120.19
2.0
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3397
23537
1.69
119.84
3.5
3.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
178
252
7.18
119.00
1.5
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
625
2321
2.81
118.24
2.2
1.6
g/l
0.2
0.2
5.75
580
2198
(3019309) Folate [Moles/volume] in Red Blood Cells
2324
14532
1.80
117.93
2.0
1.7
nmol/l
1211.3
1167.0
1.42
1833
10933
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
71
18
39.73
116.54
10.0
7.4
—
—
—
0
0
(4212803)
101
66
15.46
116.17
1.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
93
52
18.05
115.62
1.5
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
631
2394
2.75
114.52
2.1
1.6
g/l
1.1
1.2
4.98
594
2264
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
676
2667
2.65
113.58
4.7
3.2
u/ml
0.3
0.3
0.55
430
1517
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
163
221
7.49
113.25
4.4
2.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
954
4450
2.27
111.03
1.8
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
171
251
6.92
110.60
1.8
2.0
u/ml
459.1
24618.1
0.88
15
36
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
487
1635
3.09
110.40
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
487
1635
3.09
110.40
1.6
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
116
105
11.17
109.90
1.4
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
2707
18036
1.70
108.08
1.8
1.5
nmol/l
20.1
20.4
0.54
2438
15381
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
156
214
7.40
107.27
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
490
1683
3.02
106.70
3.1
2.5
%
15.9
16.4
1.11
255
881
(3024980) IgG subclass 4 [Mass/volume] in Serum
411
1276
3.32
106.11
1.6
1.6
g/l
0.8
0.8
0.54
293
968
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3194
22317
1.65
105.82
3.7
3.0
ng/l
1709.4
1387.2
2.52
2789
19190
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
149
197
7.67
105.82
2.4
1.8
u/l
60.8
35.0
0.72
143
178
(3024471) HLA-A [Type]
160
230
7.06
105.49
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
230
471
4.98
105.13
1.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
358
1037
3.55
103.02
2.5
2.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
175
292
6.09
99.97
4.0
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
174
290
6.09
99.51
4.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
174
290
6.09
99.51
4.0
1.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
348
1015
3.52
99.07
7.5
6.3
mg/l
11.7
11.6
0.06
326
931
(3000494) Fungus identified in Specimen by Culture
1575
9179
1.86
98.51
1.9
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
405
1309
3.19
97.81
5.6
3.6
u/ml
57.8
30.3
1.54
399
1267
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
556
2144
2.69
97.46
1.5
1.4
iu/ml
12.6
13.6
0.06
13
47
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
198
382
5.27
96.90
3.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
198
382
5.27
96.90
3.7
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
198
382
5.27
96.90
3.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
198
382
5.27
96.90
3.7
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1318
7285
1.94
96.87
7.0
4.0
kpa
5.8
5.8
1.91
1273
7075
(3002032) Base excess in Venous blood by calculation
1314
7258
1.94
96.76
7.0
4.0
mmol/l
1.9
1.9
0.09
1067
5906
(3000991) Gas panel - Venous blood
1232
6683
1.97
95.60
11.0
8.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
151
227
6.74
95.51
1.3
1.1
—
—
—
0
0
(3012544) pH of Venous blood
1348
7552
1.92
95.01
7.0
4.0
ph
7.4
7.4
0.46
15
41
(3016650) Hepatitis A virus Ab [Presence] in Serum
385
1229
3.22
94.90
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4254
32463
1.57
94.23
2.8
2.3
nmol/l
77.0
77.5
0.67
3921
29169
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3946
29609
1.57
94.10
4.6
3.6
ng/l
59.8
69.4
0.15
3012
20266
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2751
19042
1.63
91.72
4.6
2.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
729
3289
2.32
91.15
1.9
1.9
u/l
41.5
39.0
1.97
643
2892
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
968
4915
2.08
90.03
5.8
3.9
mmol/l
2.1
1.8
2.58
713
3661
(3035350) Ketones [Presence] in Urine by Test strip
4820
38090
1.54
89.48
4.6
3.7
estimate
0.0
0.0
1.08
1475
6888
(3041096) Erythrocytes [Presence] in Urine by Automated
2889
20356
1.60
88.94
4.5
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
4830
38234
1.54
88.62
6.0
4.9
estimate
0.0
0.0
0.80
1494
7012
(3009343) pH of Capillary blood
988
5092
2.05
88.16
5.8
4.0
ph
7.4
7.4
0.79
200
617
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
8571
78167
2.06
88.02
33.7
14.1
mg/l
24.5
23.9
0.99
7673
62013
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
178
341
5.30
87.80
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
379
1259
3.09
87.30
1.1
1.1
—
—
—
0
0
(4062490)
290
816
3.63
87.12
1.4
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
4862
38663
1.53
86.47
4.7
3.7
estimate
0.0
0.0
0.26
1446
6838
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
991
5155
2.03
86.10
5.9
4.0
kpa
5.1
5.2
0.93
924
4776
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
4175
32156
1.54
85.93
2.2
2.0
pmol/l
92.0
95.9
6.13
2479
16572
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1947
12519
1.70
85.52
3.8
3.0
e6/l
2.7
2.5
0.28
1158
6781
(3024139) IgG subclass 3 [Mass/volume] in Serum
285
815
3.57
83.56
1.4
1.4
g/l
0.4
0.4
0.03
191
572
(3027135) IgG subclass 1 [Mass/volume] in Serum
285
815
3.57
83.56
1.4
1.4
g/l
7.3
6.7
0.88
190
575
(3028192) IgG subclass 2 [Mass/volume] in Serum
285
816
3.57
83.41
1.4
1.4
g/l
2.6
2.9
2.27
190
574
(3014111) Lactate [Moles/volume] in Serum or Plasma
1219
6882
1.89
83.12
9.2
6.9
mmol/l
1.4
1.3
1.69
1182
6621
(3029937) Albumin [Presence] in Urine by Test strip
2881
20560
1.58
82.71
5.0
4.1
estimate
0.0
0.0
2.60
1396
6763
(3025941) Bacteria identified in Stool by Culture
851
4246
2.10
82.63
1.4
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
372
1262
3.03
82.59
2.3
1.9
mmol/l
1.7
1.7
0.11
359
1237
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2158
14393
1.65
81.87
4.4
3.0
mmol/l
2.5
2.5
1.64
1922
12538
(3032352) Blasts [#/volume] in Cerebral spinal fluid
82
69
11.98
81.42
4.2
3.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
495
1970
2.60
81.21
3.6
3.1
mmol/l
24.7
24.9
0.34
452
1720
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
67
40
16.86
80.61
3.1
3.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
309
957
3.30
79.97
2.5
2.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
493
1974
2.58
79.86
6.3
4.1
kpa
8.2
8.4
0.98
466
1837
(3005322) IgE [Units/volume] in Serum or Plasma
914
4740
2.03
79.81
1.8
1.3
u/ml
339.4
214.2
1.84
829
4381
(3022806) Fractional oxyhemoglobin in Capillary blood
318
1007
3.23
79.36
2.4
1.8
%
88.4
89.9
2.66
310
992
(40768804) Tissue Pathology biopsy report
4129
32091
1.51
79.20
2.4
2.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
785
3859
2.13
79.12
8.1
4.4
mmol/l
24.1
24.1
0.02
726
3472
(3014576) Chloride [Moles/volume] in Serum or Plasma
1581
9802
1.74
78.56
10.5
6.9
mmol/l
104.1
104.5
2.15
1546
9599
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
98
114
8.68
77.37
1.6
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
393
1425
2.83
77.32
3.1
2.9
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
171
355
4.89
76.93
33.5
25.9
ug/l
128.3
113.5
1.73
144
294
(3027801) Oxygen [Partial pressure] in Arterial blood
1455
8931
1.74
74.56
9.1
7.2
kpa
11.9
12.4
3.54
1404
8515
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1454
8935
1.74
74.18
9.2
7.2
kpa
5.1
5.1
0.47
1400
8527
(3013862) HLA-DP [Type]
51
20
25.63
73.20
1.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1445
8904
1.74
72.89
9.2
7.2
mmol/l
1.4
1.0
2.24
1159
6984
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
527
2274
2.40
72.60
1.4
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
401
1523
2.71
72.16
1.4
1.2
titre
104.4
176.8
—
9
37
(3052851) Hemolysis interference index of Serum or Plasma
544
2391
2.35
71.87
4.3
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
7298
64521
1.58
71.50
40.5
17.2
%
14.5
13.7
201.60
7224
63157
(40763590) HLA-DQ beta [Type]
50
20
25.13
71.24
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
50
20
25.13
71.24
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
50
20
25.13
71.24
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
50
20
25.13
71.24
1.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
91
107
8.58
71.23
1.8
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
866
4607
1.97
69.96
2.1
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
970
5378
1.90
69.23
4.3
2.9
e9/l
4.0
4.1
0.58
747
4147
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3172
23841
1.50
68.70
2.7
2.1
u/l
181.5
216.3
1.36
2982
22322
(3016502) Oxygen saturation in Arterial blood
1311
7988
1.74
68.48
9.7
7.6
%
95.0
95.7
2.90
1271
7694
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
67
54
12.49
68.31
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
343
1239
2.83
67.91
1.2
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
121
210
5.82
66.43
2.0
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
292
979
3.05
66.13
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
455
1916
2.44
66.09
1.3
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
79
86
9.25
65.64
2.0
1.9
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
52
28
18.67
65.63
1.3
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
152
327
4.71
65.55
36.2
34.4
ug/l
7.5
7.3
0.31
136
296
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
128
239
5.42
65.00
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1223
7423
1.74
64.49
3.2
2.4
u/l
33.1
44.8
1.11
1088
6329
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
49
24
20.52
64.45
2.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
404
1636
2.54
63.79
3.8
2.8
umol/l
36.1
34.3
0.66
340
1398
(3034770) Mitochondria Ab [Titer] in Serum
486
2162
2.32
62.32
1.2
1.2
titre
710.0
901.4
0.35
12
77
(3028433) Virus identified in Specimen by Culture
130
257
5.11
61.94
1.3
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
122
228
5.41
61.90
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1956
13538
1.56
60.94
3.6
2.8
e6/l
1.1
1.4
0.77
1181
7749
(3024891) Influenza virus A+B Ag [Presence] in Specimen
450
1980
2.34
59.16
1.4
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
480
2175
2.27
58.90
1.3
1.2
titre
165.3
156.9
0.06
45
193
(3019060) Gas panel - Arterial blood
894
5090
1.84
58.22
6.1
4.9
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
44
22
20.09
57.32
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
126
260
4.90
57.15
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2126
15167
1.52
57.13
4.2
3.7
ng/l
504.7
486.4
0.04
1701
11800
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
38
13
29.34
56.97
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1010
6011
1.76
56.61
6.6
3.5
kpa
4.8
4.6
1.17
969
5818
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3690
29325
1.42
56.56
4.9
3.9
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1177
7367
1.68
54.84
10.4
7.9
g/l
116.9
121.4
8.97
1141
7103
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
208
642
3.29
54.15
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
247
846
2.97
53.88
1.2
1.2
u/l
88.0
63.1
1.05
181
562
(3019550) Sodium [Moles/volume] in Serum or Plasma
8590
80358
1.77
53.65
33.3
16.3
mmol/l
139.2
139.7
50.07
8458
78417
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
498
2385
2.15
53.23
1.6
1.6
iu/ml
0.3
4.5
0.96
107
518
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
494
2359
2.15
53.20
2.3
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1612
10979
1.56
53.04
1.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
317
1249
2.59
52.94
1.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
6256
54834
1.42
52.78
4.8
3.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5901
51202
1.41
52.74
4.5
3.1
u/l
65.6
48.1
20.08
5549
47602
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
110
220
5.05
51.76
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
8596
80583
1.75
51.21
34.2
16.4
mmol/l
4.0
4.0
1.20
8452
78478
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
612
3252
1.94
49.09
3.3
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
502
2495
2.07
48.62
2.0
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
582
3053
1.97
48.47
1.3
1.2
u/ml
0.4
1.0
2.19
30
291
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
281
1093
2.62
48.18
3.5
2.6
u/ml
144.1
1421.5
0.81
270
1049
(3051651) Icteric interference index of Serum or Plasma
165
476
3.51
47.80
4.9
3.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
232
823
2.86
47.52
1.5
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
395
1812
2.23
46.97
2.6
2.2
g/l
126.9
129.9
1.11
314
1297
(3002256) Pathology report gross observation
1499
10304
1.54
46.73
1.4
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
290
1163
2.54
46.70
1.3
1.2
u/ml
4.0
3.7
0.05
112
382
(21494890) Protein electrophoresis panel - 24 hour Urine
225
804
2.84
45.48
2.1
2.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
83
147
5.69
44.68
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
139
375
3.75
44.51
2.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
139
375
3.75
44.51
2.2
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
701
4013
1.81
44.43
6.3
3.6
u/ml
52.1
55.7
0.22
677
3864
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
540
2846
1.95
44.30
3.7
3.5
u/ml
1547.4
2210.0
0.17
473
2428
(3009214) Lutropin [Units/volume] in Serum or Plasma
414
1992
2.13
43.65
1.6
1.4
u/l
10.9
10.6
0.15
335
1593
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
378
1758
2.20
43.45
2.2
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
278
1135
2.49
43.12
1.3
1.2
u/ml
4.3
4.3
0.00
131
495
(3012441) Differential panel - Pleural fluid
220
803
2.78
42.75
1.5
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
246
952
2.63
42.63
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2711
21184
1.39
42.61
1.6
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
511
2692
1.95
41.95
2.8
2.3
ug/l
515.3
563.8
0.10
481
2530
(3019420) Tryptase [Mass/volume] in Serum or Plasma
139
391
3.59
41.88
1.9
1.5
ug/l
11.0
8.1
0.87
124
351
(3003434) Protein [Mass/volume] in Pleural fluid
260
1045
2.53
41.69
1.5
1.5
g/l
34.0
32.4
1.28
236
937
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
184
621
3.00
41.26
1.2
1.2
titre
201.9
200.8
0.01
31
114
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
184
621
3.00
41.26
1.2
1.2
titre
234.3
217.7
—
7
22
(3022145) Colonoscopy Study observation
1292
8818
1.54
41.16
1.4
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
705
4136
1.76
41.03
11.0
9.2
mmol/l
24.4
24.3
0.41
675
3860
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
160
504
3.21
40.37
2.1
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2200
16731
1.41
40.08
1.7
1.7
pmol/l
32380912.6
33439305.6
0.03
1819
13897
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
358
1684
2.17
39.99
2.3
1.5
e6/l
41.5
23.0
0.25
302
1291
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
358
1684
2.17
39.99
2.4
1.5
e6/l
396.0
1214.2
2.45
319
1363
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
333
1523
2.23
39.88
1.7
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
161
518
3.14
39.22
2.1
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
392
1926
2.08
39.10
2.1
1.4
mg/l
606.3
516.7
0.67
375
1832
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
157
499
3.18
39.04
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
337
1567
2.19
38.75
2.4
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7881
73295
1.46
38.48
29.3
13.2
ml/min/173m2
80.6
80.7
0.12
7048
60539
(3014148) Varicella zoster virus Ab [Titer] in Serum
225
877
2.60
38.46
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
539
2981
1.86
38.10
2.3
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
361
1741
2.12
37.83
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
245
1003
2.48
37.81
2.5
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
202
756
2.71
37.44
3.6
2.9
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
142
437
3.28
37.24
3.0
2.5
%
93.5
96.8
0.43
137
407
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
251
1047
2.44
37.20
1.1
1.1
g/l
1.6
1.5
2.70
229
939
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
931
6027
1.60
37.14
4.9
3.8
ng/l
96.7
90.2
1.14
817
5180
(3025468) Yersinia sp identified in Specimen by Organism specific culture
243
1000
2.47
37.09
2.6
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
794
4949
1.66
36.88
11.5
9.0
%
93.4
94.0
1.93
787
4930
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
243
1003
2.46
36.85
2.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
247
1028
2.44
36.79
2.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
243
1006
2.45
36.61
2.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
244
1014
2.44
36.46
2.6
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
77
155
5.00
36.05
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
126
368
3.46
35.91
1.7
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
167
581
2.91
35.53
1.6
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
190
711
2.71
35.25
1.5
1.5
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
130
394
3.33
34.97
1.2
1.1
u/l
39.9
25.4
1.29
99
294
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
345
1687
2.08
34.86
2.1
1.4
mmol/l
3.8
3.8
0.21
327
1584
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
130
396
3.31
34.69
1.2
1.1
u/l
104.7
87.9
1.02
106
308
(3008152) Bicarbonate [Moles/volume] in Arterial blood
770
4843
1.64
34.44
9.2
7.1
mmol/l
24.7
24.6
0.29
734
4512
(40757373) Influenza virus identified in Isolate
71
139
5.14
34.32
1.7
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
696
4269
1.68
34.31
12.4
9.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
298
1387
2.19
34.20
1.6
1.4
mmol/l
64.2
63.8
0.06
234
1118
(3022313) Gas panel - Capillary blood
630
3765
1.72
34.20
7.0
4.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
988
6616
1.55
33.90
3.3
2.9
ng/l
231.6
193.2
1.83
899
6022
(3022493) Free Hemoglobin [Mass/volume] in Plasma
111
310
3.61
33.88
4.3
4.6
mg/l
2002.7
66.3
0.49
95
220
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
777
4923
1.63
33.73
11.6
9.0
%
0.7
0.7
1.06
769
4888
(3035637) Corticotropin [Mass/volume] in Plasma
241
1032
2.37
33.72
1.7
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
205
821
2.53
33.18
4.7
3.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
250
1097
2.31
33.08
1.1
1.1
%
113.6
117.2
0.85
224
989
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
322
1565
2.09
33.07
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
6588
59962
1.33
32.96
4.6
4.0
pmol/l
14.9
14.8
1.15
6040
54481
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
111
316
3.54
32.93
2.5
2.1
ug/l
38.2
203.6
0.82
105
290
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
775
4940
1.62
32.80
11.5
8.9
%
1.4
1.4
0.78
768
4907
(3008295) Osmolality of Serum or Plasma
199
793
2.54
32.55
1.6
1.4
mosm/kgh2o
277.5
279.7
0.69
169
608
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
135
439
3.11
32.37
13.1
18.1
nmol/l
1364.7
1426.2
0.31
126
424
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
184
710
2.62
32.16
1.3
1.3
u/l
735.7
342.6
0.82
175
670
(3013512) EKG study
2802
22802
1.33
31.75
4.5
3.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
747
4786
1.61
30.91
3.3
3.3
pmol/l
4.5
4.5
0.03
630
4246
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
268
1247
2.18
30.81
1.2
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
111
332
3.37
30.54
1.3
1.8
%
151.1
149.5
0.06
105
311
(4306422)
250
1136
2.23
30.47
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
160
594
2.72
30.20
1.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
55
96
5.76
30.13
1.2
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
81
197
4.14
30.07
1.3
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
215
923
2.36
29.95
1.5
1.5
e6/l
6170.6
2227.3
0.50
172
658
(3023420) DNA double strand Ab [Units/volume] in Serum
197
814
2.45
29.87
1.9
1.4
iu/ml
30.5
23.4
0.90
16
34
(3007919) Fasciola sp Ab [Titer] in Serum
22
10
22.05
29.55
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
144
512
2.84
29.51
1.6
1.6
u/l
6.6
5.5
0.28
78
243
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
293
1442
2.06
29.13
3.9
3.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
422
2352
1.83
29.05
1.4
1.4
ug/g
271.4
273.1
0.06
267
1376
(21491868) Cryoglobulin [Mass/volume] in Serum
96
270
3.58
29.05
1.3
1.2
g/l
0.3
0.2
—
6
19
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
1.1
1.7
0.41
27
36
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
3.0
3.7
0.22
26
31
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
1.7
0.9
0.39
21
33
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
1.9
3.1
0.66
26
31
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
1.2
0.7
0.45
23
37
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
0.7
2.0
1.27
28
39
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
3.0
1.5
0.54
23
38
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
2.2
1.5
0.21
19
31
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
40
52
7.72
28.87
1.7
1.5
mg/l
1.3
1.8
0.26
30
35
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
26
18
14.48
28.77
1.0
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
648
4086
1.63
28.57
3.8
2.7
e6/l
0.2
0.3
1.79
637
3978
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
73
171
4.29
28.48
1.5
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
370
1991
1.89
28.46
1.3
1.3
u/ml
14.0
7.0
0.83
75
307
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
247
1150
2.18
28.37
1.2
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
41
56
7.35
28.36
1.7
1.6
mg/l
1.4
1.2
0.09
22
35
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
150
557
2.72
28.33
1.3
1.3
u/l
15.1
12.4
0.41
141
511
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
366
1968
1.89
28.22
1.3
1.3
u/ml
10.3
3.4
0.65
56
193
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
126
429
2.96
27.95
10.0
12.6
nmol/l
758.5
825.2
0.84
120
407
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
122
409
3.01
27.81
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
178
726
2.48
27.78
3.5
3.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
218
973
2.27
27.77
1.5
1.4
nmol/l
0.2
0.4
2.65
145
745
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
390
2152
1.85
27.73
1.3
1.3
u/ml
31.6
38.4
0.23
23
131
(3042733) HLA Ab [Presence] in Serum
88
241
3.68
27.72
5.2
4.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
195
834
2.37
27.43
1.5
1.5
e6/l
95412.4
56409.8
0.46
127
484
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
8664
83055
1.53
27.23
23.0
10.4
u/l
27.3
26.4
2.58
8502
80090
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
155
598
2.62
27.16
1.4
1.3
mmol/l
2.4
2.0
1.38
144
564
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
312
1626
1.95
26.43
1.3
1.2
u/ml
8.7
3.8
0.35
28
111
(4268621)
182
771
2.39
26.17
2.4
2.3
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
62
138
4.52
25.83
1.3
1.3
titre
40.6
101.6
—
8
19
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
113
379
3.01
25.77
1.8
1.3
%
61.1
63.9
0.11
20
47
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
139
523
2.68
25.63
2.4
1.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
314
1660
1.92
25.50
3.7
3.4
u/ml
242.7
593.2
1.11
286
1514
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
133
491
2.73
25.45
1.1
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
131
480
2.75
25.43
1.2
1.2
u/l
33.0
23.1
1.03
118
399
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
133
493
2.72
25.25
1.1
1.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
133
494
2.72
25.15
1.2
1.2
u/l
142.9
86.9
1.09
121
425
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
40
61
6.58
25.06
1.3
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
308
1629
1.92
24.99
1.2
1.2
u/ml
2.2
19.8
—
5
21
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
110
370
3.00
24.98
2.9
5.2
u/ml
49.1
10149.9
—
8
63
(3036782) Glucose [Moles/volume] in Pleural fluid
170
715
2.40
24.86
1.4
1.4
mmol/l
6.1
6.4
0.77
159
657
(3027273) Bicarbonate [Moles/volume] in Venous blood
579
3673
1.61
24.86
5.0
3.4
mmol/l
25.1
25.2
0.33
557
3557
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
186
814
2.31
24.86
1.2
1.1
%
90.3
96.2
1.98
171
765
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
553
3488
1.62
24.30
5.7
2.9
%
0.7
0.7
0.04
536
3332
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
531
3320
1.64
24.17
7.7
4.4
mmol/l
24.9
24.8
0.65
490
3068
(3018405) Lactate [Moles/volume] in Arterial blood
453
2718
1.70
24.16
4.9
4.0
mmol/l
1.5
1.4
0.75
445
2672
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
186
826
2.28
24.03
1.6
1.8
titre
811.4
1653.3
—
7
30
(3004119) Hemoglobin [Mass/volume] in Venous blood
696
4655
1.53
23.73
6.2
3.4
g/l
122.0
129.2
10.66
676
4533
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2118
17158
1.30
23.42
1.3
1.3
u/ml
1.2
1.8
2.06
537
4512
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
110
384
2.89
23.40
3.9
4.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
137
537
2.57
23.31
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
70
185
3.80
23.27
1.4
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
448
2711
1.68
23.15
3.9
3.2
g/l
0.4
0.3
0.37
275
1156
(3023323) Follitropin [Units/volume] in Serum or Plasma
506
3160
1.64
23.14
1.6
1.4
iu/l
26.9
29.7
1.13
429
2691
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
104
356
2.94
22.93
1.2
1.1
u/ml
31.9
23.5
0.12
13
32
(3020891) Body temperature
495
3091
1.63
22.64
5.9
4.8
—
—
—
0
0
(3004451) EKG impression Narrative
107
377
2.86
22.40
1.4
1.3
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
28
32
8.77
22.39
1.2
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
190
878
2.19
22.32
9.8
13.7
mmol/l
7.5
7.3
0.17
164
741
(3029634) Reagin Ab [Titer] in Serum by VDRL
208
997
2.11
22.26
1.9
2.0
titre
17.0
2.8
—
8
23
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
378
2207
1.74
22.26
1.3
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
70
191
3.68
22.24
1.5
1.4
g/l
13.0
13.5
0.16
48
153
(3014765) Yersinia sp identified in Stool by Organism specific culture
380
2227
1.74
22.08
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
381
2236
1.73
22.03
1.3
1.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
82
250
3.30
22.00
1.3
1.9
%
187.4
179.9
0.23
77
237
(3045788) Cell count panel - Pleural fluid
163
713
2.31
21.86
1.6
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
179
816
2.22
21.76
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1251
9481
1.37
21.72
2.7
2.3
ug/g
183.6
131.4
1.66
1013
7442
(3009466) Valproate [Moles/volume] in Serum or Plasma
221
1094
2.04
21.71
6.4
5.0
umol/l
393.4
365.1
2.02
193
942
(3019832) Treponema pallidum Ab [Presence] in Serum
816
5744
1.46
21.62
1.6
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
139
570
2.46
21.55
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
139
570
2.46
21.55
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
139
571
2.46
21.47
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
48
101
4.77
21.45
2.2
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
119
454
2.64
21.42
1.2
1.1
ratio
1.1
1.1
0.97
54
151
(3017704) Immunofixation for Urine
111
409
2.73
21.39
1.9
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
139
573
2.45
21.31
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
139
573
2.45
21.31
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
139
574
2.44
21.23
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1348
10369
1.35
21.23
23.4
24.9
inr
1.4
1.3
1.32
204
1490
(40768446) Kidney Pathology biopsy report
91
303
3.02
21.10
1.6
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
180
835
2.18
20.97
2.4
1.5
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
78
238
3.30
20.92
1.8
1.3
%
28.0
26.0
0.08
20
32
(3001893) Eosinophils/100 leukocytes in Pleural fluid
77
234
3.31
20.79
1.5
1.4
%
1.2
2.8
1.78
69
194
(21494755) Public health laboratory ask at order entry panel
434
6802
0.62
20.55
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
221
1120
2.00
20.37
1.4
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
526
3436
1.56
19.91
5.3
4.0
%
49.4
48.4
0.39
521
3392
(3052592) Norovirus Ag [Presence] in Stool
57
146
3.92
19.84
1.5
1.3
—
—
—
0
0
(3036603) Volume of Urine
129
532
2.44
19.79
1.5
1.6
ml
2134.6
1913.5
0.38
23
126
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
120
480
2.52
19.65
1.4
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
112
434
2.60
19.58
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1670
13389
1.30
19.49
1.3
1.3
iu/ml
41.8
34.8
0.70
528
4135
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
181
867
2.11
19.46
1.2
1.1
—
2.2
—
0
18
(3035947) Staphylolysin Ab [Units/volume] in Serum
101
373
2.73
19.42
1.1
1.1
iu/ml
4.6
3.6
—
10
18
(3020876) Protein [Mass/time] in 24 hour Urine
148
656
2.28
19.30
1.8
1.9
g/24h
1.2
1.6
—
8
36
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
120
485
2.49
19.24
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
116
462
2.53
19.18
1.2
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
75
236
3.20
19.17
1.9
1.8
e6/l
17624.5
19287.7
0.05
51
128
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
147
654
2.27
19.01
1.3
1.3
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
20
18
11.13
18.87
2.0
2.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
101
379
2.68
18.84
2.0
2.2
ml
1797.5
1947.4
0.70
90
333
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
31
49
6.34
18.79
1.2
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
128
540
2.39
18.71
1.6
1.2
mmol/l
32.2
34.4
0.62
111
466
(3019225) pH of Specimen
1048
7904
1.37
18.59
7.2
4.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
284
1610
1.79
18.56
1.3
1.2
u/ml
47.5
42.1
0.26
39
164
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
83
283
2.95
18.51
1.5
1.4
%
64.2
65.1
0.08
69
227
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
125
525
2.40
18.46
1.5
1.4
u/ml
3.3
1.2
0.68
52
242
(3023487) Leukocytes [#/volume] in Peritoneal fluid
79
266
2.99
18.03
2.1
2.1
e6/l
2204.5
3703.2
0.18
60
181
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
359
2191
1.66
18.00
3.1
2.2
u/l
5941.1
4970.2
0.15
116
846
(40761511) CBC panel - Blood by Automated count
8405
80969
1.35
17.58
27.6
13.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
61
179
3.42
17.46
1.2
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
80
277
2.90
17.39
4.2
2.4
nmol/l
185.2
144.0
2.69
72
237
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
120
4.02
17.31
4.7
5.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
526
3548
1.51
17.19
1.3
1.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
45
108
4.18
17.13
1.2
1.4
nmol/l
505414.2
153853.5
0.30
37
91
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
22
26
8.48
17.12
2.4
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
24
32
7.52
16.94
2.3
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
484
3220
1.53
16.88
7.4
5.1
%
1.8
1.6
2.06
454
3011
(3039162) Centromere protein B Ab [Units/volume] in Serum
190
981
1.96
16.68
1.3
1.3
u/ml
46.7
55.9
0.21
15
65
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
86
318
2.72
16.56
3.1
2.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
73
248
2.96
16.44
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
434
6476
0.65
16.31
1.7
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
385
2455
1.59
16.20
8.6
6.1
mmol/l
1.4
1.3
1.12
337
2162
(3009871) Measles virus Ab [Titer] in Serum
72
245
2.95
16.17
1.7
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1623
13254
1.27
16.05
1.6
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
93
364
2.57
16.02
1.2
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
121
536
2.27
15.88
1.4
1.4
umol/l
13.0
12.8
0.05
116
507
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
336
2085
1.63
15.82
1.2
1.3
miu/ml
175.6
221.0
1.44
108
943
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
55
162
3.41
15.69
5.3
4.6
u/l
71.2
85.6
0.16
20
56
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
97
394
2.48
15.48
1.2
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
104
437
2.40
15.42
2.7
2.8
ph
7.4
7.4
1.76
50
153
(40761539) Cells [Type] in Urine sediment by Light microscopy
62
199
3.13
15.41
1.2
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
64
210
3.06
15.33
1.2
1.3
ug/l
236.8
269.6
0.07
34
118
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
152
748
2.05
15.31
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
7520
71686
1.24
15.25
5.5
4.8
mu/l
2.3
2.1
0.29
6967
65578
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
99
411
2.42
15.08
1.3
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
69
239
2.90
15.04
1.6
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1545
12644
1.27
14.91
1.3
1.3
u/ml
17.4
12.2
1.46
502
4849
(3018738) Hemoglobin F/Hemoglobin.total in Blood
27
47
5.76
14.90
2.1
3.5
%
4.2
5.3
—
8
17
(3017446) Testosterone [Moles/volume] in Serum or Plasma
739
5456
1.38
14.87
2.9
2.1
nmol/l
12.0
12.6
1.24
661
4779
(3007930) Methemoglobin/Hemoglobin.total in Blood
468
3182
1.50
14.74
7.7
5.2
%
1.0
0.9
0.47
438
2983
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
41
103
3.99
14.73
4.3
5.8
ug/min
42.1
45.0
0.13
36
79
(3017569) Oxygen content in Arterial blood
92
377
2.45
14.44
2.4
2.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
44
119
3.71
14.28
1.9
3.0
mg/l
75.8
30.1
—
5
25
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
267
4297
0.61
14.08
1.5
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
23
36
6.40
14.08
3.3
5.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
356
2308
1.56
13.99
1.8
1.7
mu/l
334.9
305.5
0.66
323
2094
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
38
94
4.05
13.95
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
83
332
2.51
13.73
2.9
1.8
umol/l
27.3
28.8
0.42
83
321
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
66
236
2.81
13.62
1.2
1.1
%
76.2
91.2
2.69
36
108
(3016750) Collection duration of Urine
101
447
2.27
13.36
2.1
2.2
min
528.8
495.1
2.36
67
337
(3044007) Cell count panel - Peritoneal fluid
62
217
2.87
13.31
1.8
2.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
64
229
2.81
13.20
1.2
1.2
%
76.3
90.1
1.66
35
109
(3004616) Nuclear Ab [Presence] in Serum
173
938
1.86
13.20
1.4
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
94
406
2.33
13.17
15.0
11.6
mmol/l
0.6
0.6
0.13
89
369
(3023383) Lactate [Moles/volume] in Pleural fluid
66
242
2.74
13.01
1.3
1.3
mmol/l
3.6
3.4
0.30
61
214
(3024928) Oxygen saturation in Venous blood
262
1608
1.65
12.95
8.0
3.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
63
226
2.80
12.94
1.3
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
58
199
2.93
12.92
2.4
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2827
24920
1.19
12.92
3.7
3.2
mmol/l
7.2
7.5
3.06
2336
20894
(3043409) Potassium [Moles/volume] in Arterial blood
353
2328
1.54
12.88
5.4
4.3
mmol/l
3.9
3.9
0.17
322
2190
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5203
48279
1.17
12.71
3.3
2.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
326
2121
1.56
12.65
1.2
1.4
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
13
11
11.83
12.63
1.1
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
22
38
5.80
12.24
1.1
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1125
9060
1.27
12.24
2.0
1.7
%
1.5
1.5
2.71
963
7906
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
71
279
2.56
12.23
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
312
2027
1.56
12.19
1.1
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
148
784
1.90
12.17
1.2
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
123
612
2.02
12.12
1.2
1.2
u/ml
57.6
52.7
—
9
29
(3044242) Glucose [Moles/volume] in Arterial blood
87
379
2.31
11.99
2.3
1.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
20
32
6.26
11.99
4.9
3.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
233
1417
1.66
11.97
1.8
1.5
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
12
10
12.01
11.73
1.2
1.0
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
15
5
30.04
11.63
1.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
27
59
4.59
11.62
5.5
3.9
mg/l
2.1
2.6
0.70
22
46
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
119
595
2.01
11.59
1.2
1.2
u/ml
57.8
76.3
0.47
13
26
(3012516) Albumin [Mass/volume] in Urine
2645
23354
1.18
11.59
3.6
3.3
mg/l
1037.1
392.1
4.56
1723
14708
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
119
599
2.00
11.39
1.2
1.2
u/ml
18.8
37.3
0.59
12
45
(3011985) Renin [Units/volume] in Plasma
185
1073
1.74
11.35
1.7
1.4
mu/l
76.6
72.4
0.07
163
955
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
126
650
1.95
11.25
2.2
2.4
nmol/l
18.0
18.6
0.19
119
615
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
143
773
1.86
11.09
1.1
1.1
—
79.4
—
0
11
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
189
1111
1.72
11.06
1.4
1.3
nmol/l
0.7
2.0
0.67
181
1069
(3023410) Appearance of Cerebral spinal fluid
143
774
1.86
11.05
3.4
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
59
224
2.64
10.94
1.2
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
115
581
1.99
10.91
1.2
1.2
mg/l
68.0
40.8
0.67
83
489
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
19
32
5.95
10.84
5.2
3.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
54
197
2.75
10.81
1.3
1.4
%
23.2
24.8
0.14
45
161
(3002814) Trichinella spiralis Ab [Titer] in Serum
14
5
28.03
10.71
1.0
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
174
1011
1.73
10.63
1.3
1.3
pmol/l
427.0
318.0
0.67
135
757
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
131
700
1.88
10.56
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
46
156
2.96
10.53
1.2
1.2
%
71.9
75.6
0.20
20
42
(3034426) Prothrombin time (PT)
68
282
2.42
10.52
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
48
167
2.88
10.50
2.0
1.9
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
31
82
3.79
10.45
1.4
1.2
—
—
—
0
0
(4027681)
92
435
2.13
10.45
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
116
599
1.95
10.36
1.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
49
174
2.83
10.33
3.5
2.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
810
6395
1.29
10.28
4.1
2.6
ml/min/173m2
57.5
65.8
7.92
402
2508
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
106
532
2.00
10.27
1.1
1.1
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
14
6
23.36
10.23
1.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
98
479
2.06
10.21
2.0
1.5
u/l
6.8
5.9
0.64
78
405
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
110
562
1.97
10.14
1.1
1.1
mg/l
350.3
269.2
0.54
90
490
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
117
611
1.93
10.12
1.0
1.0
mg/l
317.8
288.1
2.04
101
547
(4281824)
154
881
1.76
9.97
1.2
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
45
156
2.89
9.93
1.2
1.2
%
72.6
79.1
0.51
19
43
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
72
315
2.30
9.90
1.1
1.1
miu/ml
1443.7
1501.3
0.17
72
315
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
264
1735
1.54
9.88
1.6
1.4
pmol/l
219.2
161.6
0.79
257
1694
(3039000) Anion gap in Blood
266
1753
1.53
9.83
10.4
7.1
mmol/l
11.2
11.2
0.02
242
1570
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
312
2126
1.48
9.83
1.5
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
266
1754
1.53
9.80
10.4
7.1
mmol/l
105.5
105.1
0.54
242
1571
(3003338) MCHC [Mass/volume]
6317
66147
0.86
9.70
43.2
18.2
g/l
330.7
332.4
33.30
6279
65661
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
170
1008
1.70
9.70
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
7378
70993
1.18
9.65
33.7
15.2
%
38.7
39.7
15.97
4982
50721
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
184
1116
1.66
9.64
1.4
1.3
nmol/l
0.2
0.3
1.58
16
70
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
31
87
3.57
9.62
1.3
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
85
404
2.11
9.57
1.6
1.8
u/field
1.9
3.1
1.05
64
282
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
84
399
2.12
9.47
1.2
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
38
123
3.10
9.45
1.7
1.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
109
571
1.92
9.38
1.3
1.2
u/ml
17.2
5.9
0.46
12
36
(3044009) aPTT.lupus sensitive (LA screen)
24
57
4.22
9.36
1.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
84
401
2.10
9.36
1.6
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
163
968
1.70
9.27
1.8
1.6
%
58.7
58.1
0.07
105
615
(3027456) Digoxin [Moles/volume] in Serum or Plasma
227
1465
1.56
9.24
3.4
3.0
nmol/l
0.8
0.8
0.18
167
1110
(3020682) Albumin/Creatinine [Ratio] in Urine
2732
24547
1.16
9.16
4.5
4.0
mg/mmol
14.3
9.3
4.07
1708
15471
(3004775) Volume in Urine collected for unspecified duration
117
633
1.86
9.14
2.2
2.2
ml
713.9
648.9
0.93
78
430
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
30
86
3.50
9.04
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
227
1473
1.55
9.03
1.9
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
842
6792
1.26
8.97
2.4
2.3
ug/l
8.9
7.3
0.69
707
5914
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
64
280
2.29
8.85
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
491
3705
1.34
8.64
1.4
1.4
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
19
40
4.76
8.57
1.2
1.0
u/field
1.2
1.0
0.30
11
26
(3011397) Hemoglobin [Presence] in Urine by Test strip
2077
18357
1.17
8.55
4.2
3.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
45
170
2.65
8.51
1.2
1.4
g/l
21.6
26.3
1.11
32
134
(3000492) Spirometry study
903
7400
1.24
8.38
1.7
1.5
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
15
26
5.78
8.32
1.4
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
37
128
2.90
8.25
1.9
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
37
128
2.90
8.25
1.9
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
37
128
2.90
8.25
1.9
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
24
63
3.82
8.22
2.0
2.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
36
123
2.93
8.20
1.2
1.2
mmol/l
3.2
1.7
0.35
22
82
(44786800) Granulocytes/100 leukocytes in Body fluid
32
102
3.14
8.20
1.3
1.3
%
39.5
24.1
1.12
26
74
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
16
30
5.34
8.19
1.1
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
17
34
5.01
8.13
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
48
192
2.51
8.11
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
48
192
2.51
8.11
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
48
192
2.51
8.11
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
48
192
2.51
8.11
1.0
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
18
38
4.74
8.10
2.7
1.5
mpas
1.8
1.7
—
10
21
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
77
377
2.05
8.08
1.0
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
66
305
2.17
8.04
1.1
1.1
ng/l
1357.2
394.5
0.41
19
69
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
33
109
3.03
7.98
1.5
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
124
714
1.75
7.94
1.7
1.5
%
32.0
30.8
0.11
75
436
(3049717) Cytology report of Urine Cyto stain
399
2956
1.37
7.94
2.5
2.7
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
47
189
2.49
7.86
1.4
1.2
umol/l
16.8
16.7
0.06
41
170
(3020961) Endomysium IgA Ab [Titer] in Serum
478
3648
1.33
7.82
1.1
1.1
titre
52.5
187.8
—
8
95
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
71
342
2.08
7.80
1.1
1.1
%
96.1
95.6
0.03
59
267
(3028707) Methadone [Presence] in Urine by Screen method
178
1133
1.58
7.76
4.4
2.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
121
697
1.75
7.75
1.7
1.4
ug/l
2.5
4.2
2.28
90
599
(3020717) Zinc [Moles/volume] in Serum or Plasma
80
405
1.98
7.68
1.7
1.5
umol/l
20.9
24.5
0.58
80
385
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
18
6.67
7.60
5.2
6.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
273
1911
1.44
7.58
1.8
1.6
e6/l
14895.0
13285.4
0.26
200
1378
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
19
45
4.23
7.46
1.1
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
51
220
2.33
7.35
1.1
1.1
—
—
—
0
0
(3017501) Neutrophils [#/volume] in Blood by Manual count
7
0
+∞
7.29
1.6
0.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
69
338
2.05
7.28
1.5
2.2
umol/l
143.7
138.3
0.03
29
190
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
35
127
2.76
7.20
2.1
1.6
nmol/l
0.1
0.2
0.81
25
79
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
65
314
2.08
7.12
1.5
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
149
929
1.61
7.12
3.6
2.3
mmol/l
4.1
4.1
0.06
149
917
(3035285) Chloride [Moles/volume] in Venous blood
149
929
1.61
7.12
3.6
2.3
mmol/l
105.2
105.6
0.36
149
917
(3033086) Enterovirus NOS Ab [Titer] in Serum
13
23
5.66
7.06
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
168
1086
1.56
6.90
1.2
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
52
233
2.24
6.89
2.5
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
145
908
1.61
6.83
3.6
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
171
1114
1.54
6.80
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
208
1413
1.48
6.79
1.5
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
34
127
2.68
6.64
1.6
1.4
%
9.0
8.6
0.04
26
65
(3019174) dRVVT (LA screen)
22
64
3.44
6.55
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
60
292
2.06
6.49
1.0
1.1
—
—
—
0
0
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
13
25
5.21
6.48
1.2
1.0
u/field
1.3
0.9
—
8
14
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
27
90
3.01
6.48
1.1
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
157
1016
1.55
6.45
1.4
1.3
u/l
28.2
28.5
0.05
137
827
(3024869) Neuronal Ab [Presence] in Serum
38
154
2.47
6.32
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
47
210
2.24
6.30
1.7
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
98
567
1.74
6.27
2.0
2.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
75
400
1.88
6.26
1.1
1.1
u/l
1.1
1.1
0.03
40
183
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
656
5373
1.24
6.15
2.4
2.4
au/ml
31.9
23.7
0.36
18
285
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
32
122
2.63
6.04
1.9
3.1
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
24
78
3.08
6.02
1.0
1.4
mmol/l
159.8
161.7
0.02
24
70
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
263
1915
1.38
5.93
1.8
1.8
iu/l
4.2
4.4
0.15
105
676
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
21
64
3.29
5.84
1.4
1.4
ml/s/173m2
1.6
1.1
1.00
13
44
(3014891) Appearance of Pleural fluid
29
107
2.72
5.83
1.7
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
84
476
1.77
5.81
1.5
1.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
17
45
3.78
5.80
1.3
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
46
212
2.18
5.76
1.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
61
313
1.95
5.75
1.2
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
84
478
1.76
5.73
1.4
1.3
titre
23.3
64.5
—
6
38
(3014271) Vancomycin [Susceptibility]
71
384
1.86
5.72
3.2
2.9
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
86
496
1.74
5.61
1.4
1.3
titre
778.0
327.1
—
5
41
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
45
208
2.17
5.60
1.3
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
622
5120
1.23
5.58
1.2
1.2
iu/ml
111.5
144.0
1.29
189
1896
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
46
216
2.14
5.51
1.2
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
274
2034
1.36
5.51
2.1
1.8
nmol/l
39.8
41.6
0.55
262
1968
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
82
1386
0.59
5.50
1.5
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
177
1220
1.46
5.45
1.6
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
72
398
1.82
5.43
1.3
1.7
mmol/24h
6.0
6.1
—
5
33
(3050129) First trimester maternal screen panel - Serum or Plasma
99
1589
0.62
5.39
1.5
1.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
17
48
3.55
5.31
1.1
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
206
1469
1.41
5.29
2.4
1.9
pmol/l
184.3
201.4
1.60
199
1384
(3022621) pH of Urine by Test strip
626
5191
1.22
5.24
3.2
3.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
68
374
1.82
5.23
1.7
1.5
%
5.5
4.0
0.51
24
87
(36660697) Celiac disease serology panel - Serum
738
6222
1.20
5.21
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
45
215
2.10
5.18
1.3
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
17
49
3.47
5.16
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
168
1160
1.46
5.15
1.0
1.1
au/ml
14.2
12.9
—
9
62
(3011648) Oxygen content in Venous blood
100
616
1.63
5.14
11.4
3.1
%
9.5
11.2
3.98
100
616
(3050794) Legionella sp Ab [Presence] in Serum
21
70
3.00
5.09
1.3
1.1
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
20
65
3.08
5.05
1.5
2.0
%
65.9
60.4
0.21
11
42
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
10
19
5.27
5.03
1.2
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
17
50
3.40
5.02
1.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
228
1671
1.37
5.00
4.9
3.2
mmol/l
1.5
1.6
0.74
223
1623
(3045716) Anion gap in Serum or Plasma
65
359
1.82
4.95
1.7
2.2
mmol/l
8.5
9.4
1.48
54
276
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
19
61
3.12
4.90
5.1
9.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
8780
86582
1.20
4.87
49.2
20.8
e9/l
260.0
250.7
11.57
8645
84339
(4198724)
58
311
1.87
4.86
1.7
2.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
30
125
2.40
4.78
1.2
1.3
u/ml
1.5
4.3
—
7
29
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
57
3.16
4.75
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
41
197
2.09
4.69
1.3
1.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
32
139
2.31
4.66
1.2
1.1
pmol/l
7.9
4.7
—
5
18
(3010937) Rubella virus Ab [Presence] in Serum
14
38
3.69
4.64
1.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
8781
86630
1.20
4.62
48.9
20.7
pg
30.5
30.3
12.34
8705
85434
(44806071)
26
103
2.53
4.61
1.2
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
587
4903
1.21
4.60
1.3
1.3
au/ml
32.5
52.9
1.62
19
212
(3024731) MCV [Entitic volume]
8781
86635
1.20
4.59
48.9
20.7
fl
92.2
91.0
55.74
8705
85440
(3002523) Influenza virus A Ag [Presence] in Specimen
162
1138
1.43
4.58
1.3
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
19
64
2.97
4.54
9.5
5.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
8781
86644
1.19
4.53
49.1
20.8
e12/l
4.3
4.5
108.43
8623
84160
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
251
1899
1.33
4.52
2.8
2.4
ug/min
155.4
101.2
0.86
138
1141
(3045414) Leukocytes [Presence] in Urine
441
3584
1.24
4.52
2.2
1.9
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
37
174
2.13
4.48
2.5
2.9
ng/l
130.3
138.1
0.08
25
83
(3013945) Hepatitis B virus e Ab [Presence] in Serum
14
39
3.59
4.48
2.3
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
87
2.65
4.47
1.2
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
8781
86659
1.19
4.44
49.2
20.8
e9/l
7.5
6.7
19.05
8626
84151
(3000963) Hemoglobin [Mass/volume] in Blood
8781
86663
1.19
4.41
49.4
20.9
g/l
129.9
135.3
135.79
8702
85469
(3003740) Influenza virus B Ag [Presence] in Specimen
161
1139
1.42
4.40
1.3
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
23
88
2.62
4.38
1.0
1.2
u/l
20.5
21.7
0.13
15
60
(3035611) Eosinophils/100 leukocytes in Synovial fluid
17
55
3.09
4.35
1.2
1.5
%
0.3
0.8
0.80
11
40
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
21
77
2.73
4.34
1.3
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
71
420
1.70
4.33
1.5
1.4
nmol/l
1.5
1.2
1.24
55
314
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
43
218
1.98
4.28
1.8
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
226
1699
1.34
4.27
4.7
2.9
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
53
290
1.83
4.22
1.5
1.5
pmol/l
14.1
16.0
1.40
43
240
(3030313) Adrenal Ab [Titer] in Serum
16
51
3.14
4.20
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
14
41
3.42
4.18
2.3
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
89
565
1.58
4.13
1.8
1.6
u/ml
28.8
23.1
—
10
127
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
364
2929
1.25
4.11
1.6
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
82
1284
0.64
4.11
1.4
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
31
141
2.20
4.10
1.8
1.6
ng/l
122.3
134.0
0.17
31
141
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
82
1283
0.64
4.09
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
82
1283
0.64
4.09
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
204
2704
0.75
4.05
1.9
1.7
mg/l
6.7
3.6
1.42
164
1918
(3019768) Coxiella burnetii Ab [Presence] in Serum
15
47
3.19
4.05
1.1
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
82
1279
0.64
4.04
1.4
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
30
136
2.21
4.00
3.0
2.0
umol/l
16.8
17.8
0.18
30
136
(3001729) Color of Synovial fluid
18
65
2.77
3.84
1.2
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
868
9861
0.87
3.82
12.3
6.9
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
108
730
1.48
3.80
1.4
1.3
e6/l
38391.9
91120.4
1.26
74
495
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
269
2115
1.28
3.72
1.1
1.1
u/ml
12.9
7.6
0.35
21
244
(3043238) Trisomy 21 risk [Likelihood] in Fetus
68
1082
0.63
3.70
1.5
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
67
410
1.64
3.65
2.2
1.7
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
46
253
1.82
3.65
3.6
2.7
umol/l
28.6
28.2
0.06
34
188
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1813
19652
0.90
3.63
4.0
4.3
%
22.1
21.9
0.21
871
9707
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
21
85
2.47
3.62
2.1
2.6
u/field
0.4
0.6
0.69
21
85
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
103
698
1.48
3.60
1.2
1.3
nmol/l
1.4
1.5
0.38
92
627
(3051387) C reactive protein [Mass/volume] in Capillary blood
218
1679
1.31
3.55
4.2
3.4
mg/l
30.1
26.4
0.82
152
1039
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
22
92
2.39
3.55
1.2
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
66
1046
0.63
3.54
1.5
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
251
1970
1.28
3.54
3.8
2.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
24
105
2.29
3.51
1.3
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
66
1043
0.63
3.50
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
150
1096
1.37
3.48
1.3
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
145
1054
1.38
3.47
1.1
1.1
u/ml
5.8
3.7
0.41
39
466
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
18
69
2.61
3.46
2.4
1.9
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
59
355
1.67
3.45
1.7
1.7
nmol/l
8.1
5.4
0.27
53
293
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
43
237
1.82
3.41
2.7
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
43
237
1.82
3.41
2.7
2.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
299
3687
0.80
3.39
1.6
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
176
1325
1.33
3.38
1.7
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
111
774
1.44
3.38
2.2
2.1
umol/l
15.4
8.1
1.25
68
555
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
33
167
1.98
3.37
1.1
1.1
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
7
10
7.00
3.36
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2222
20727
1.09
3.36
1.8
1.6
mmol/l
1.6
1.4
9.36
1816
17371
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
89
2.36
3.31
1.3
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
30
148
2.03
3.29
1.6
1.4
—
—
—
0
0
(44813793)
81
533
1.52
3.29
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
74
479
1.55
3.24
1.1
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
9
19
4.74
3.23
1.1
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
89
602
1.48
3.19
1.3
1.3
mmol/l
10.9
12.0
0.77
34
168
(3002621) Streptococcal DNAse B [Units/volume] in Serum
20
85
2.36
3.14
1.2
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
26
124
2.10
3.13
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
495
4235
1.18
3.07
2.5
2.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
44
255
1.73
2.99
1.0
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
9
21
4.29
2.99
3.8
3.3
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
14
51
2.75
2.98
1.2
1.1
u/l
1.4
5.5
—
5
9
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
18
75
2.40
2.96
1.1
1.2
umol/24h
2.1
1.7
0.55
18
75
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
26
127
2.05
2.96
1.7
1.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
16
63
2.54
2.95
1.9
3.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7711
78358
0.91
2.94
5.2
4.9
mmol/l
2.6
2.8
29.57
7087
72117
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
88
611
1.44
2.80
1.8
2.0
u/field
3.0
1.9
0.79
48
239
(4034850)
202
2542
0.79
2.80
16.5
9.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
32
172
1.86
2.80
2.7
1.8
ug/l
2.6
1.9
0.68
20
89
(3033923) Metanephrine [Moles/time] in 24 hour Urine
31
166
1.87
2.75
1.2
1.1
umol/24h
0.7
0.7
0.08
18
74
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
28
145
1.93
2.74
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
23
111
2.07
2.72
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
189
1.80
2.69
1.1
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
29
154
1.89
2.64
1.3
1.2
mmol/l
1.8
1.7
0.16
18
95
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
17
73
2.33
2.64
1.0
1.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
40
235
1.71
2.63
2.1
2.2
mg/l
9.6
9.5
0.06
34
191
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
74
504
1.47
2.63
1.0
1.1
iu/ml
7.0
10.5
0.46
18
112
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7511
76325
0.92
2.60
4.7
4.4
mmol/l
1.4
1.5
61.79
6901
70236
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
49
305
1.61
2.60
2.6
2.5
—
—
—
0
0
(4010399)
651
5765
1.14
2.59
1.6
1.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
34
192
1.77
2.57
1.4
1.6
ug/l
0.5
0.4
0.58
22
121
(3025018) Bordetella pertussis Ab [Titer] in Serum
68
458
1.49
2.56
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
284
2360
1.21
2.51
3.6
2.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
18
82
2.20
2.46
1.2
1.1
u/ml
0.3
0.4
0.14
13
49
(3017315) Amylase [Enzymatic activity/volume] in Urine
62
416
1.49
2.40
1.6
1.2
u/l
408.5
305.6
0.35
54
380
(3000764) Benzodiazepines [Presence] in Urine
302
2537
1.20
2.39
3.5
2.1
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
5
8
6.25
2.37
1.6
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
50
321
1.56
2.36
4.2
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
14
58
2.42
2.36
1.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
12
46
2.61
2.35
1.3
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
58
387
1.50
2.31
1.3
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
303
2556
1.19
2.30
3.6
2.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
28
155
1.81
2.29
3.4
2.5
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
14
59
2.37
2.29
1.4
1.8
%
12.7
18.1
—
6
33
(3025315) Body weight
14
59
2.37
2.29
6.1
4.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
18
85
2.12
2.28
7.1
5.1
g/mol
141.5
62.0
0.31
18
73
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
21
106
1.98
2.25
1.3
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
98
725
1.36
2.24
4.1
4.8
u/ml
48.9
77.0
0.55
22
211
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
9
29
3.11
2.22
5.0
5.2
umol/l
390.7
398.5
—
9
29
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
14
60
2.34
2.21
1.3
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
24
128
1.88
2.20
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
301
2550
1.19
2.20
3.5
2.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
10
36
2.78
2.20
1.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
11
42
2.62
2.18
2.0
3.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
15
67
2.24
2.17
1.3
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
454
3979
1.15
2.15
4.5
3.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1314
14121
0.92
2.15
2.8
3.0
ug/l
0.7
0.8
0.30
895
9527
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
14
61
2.30
2.14
1.1
1.3
—
47.3
—
0
22
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
14
61
2.30
2.14
1.1
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
5
10
5.00
2.07
1.6
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
82
2.08
2.06
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
19
96
1.98
2.04
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7584
76877
0.93
2.04
4.8
4.4
mmol/l
4.5
4.7
41.95
7035
71177
(3034614) HLA Ag [Interpretation]
6
15
4.00
2.04
1.5
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
90
670
1.35
2.01
1.1
1.2
nmol/l
323.1
355.0
0.75
76
562
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
21
111
1.89
2.00
1.3
1.3
u/l
322.7
335.6
0.01
15
80
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
9
32
2.81
2.00
1.6
1.1
nmol/l
313.3
277.3
—
9
32
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
64
451
1.42
1.98
1.1
1.1
nmol/l
5.7
9.7
0.38
11
102
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
15
70
2.14
1.98
1.3
1.2
ug/l
51.2
114.0
—
10
41
(3026726) Creatinine [Moles/volume] in Specimen
15
70
2.14
1.98
1.9
2.3
umol/l
228.5
462.2
0.42
15
64
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
899
9786
0.91
1.97
4.4
4.5
%
31.1
32.5
3.54
658
6647
(1761482) Bacteria [#/volume] in Urine by Culture
236
1980
1.20
1.96
5.0
4.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1782
16829
1.07
1.93
4.9
4.1
kg/l
1.0
1.0
0.66
283
2523
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
33
203
1.63
1.91
1.4
1.3
nmol/l
113.9
125.4
0.16
25
150
(40765089) Chromosome analysis panel - Blood by G-banded
31
188
1.65
1.90
1.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
29
173
1.68
1.89
2.5
2.3
mmol/l
7.6
7.8
0.08
14
105
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
39
251
1.56
1.88
1.3
1.2
%
103.4
110.2
0.50
33
219
(3027944) Amphetamines [Presence] in Urine
292
2509
1.17
1.85
3.4
2.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
41
269
1.53
1.83
1.3
1.2
g/l
0.3
0.3
1.21
29
216
(3014051) Protein [Presence] in Urine by Test strip
221
1857
1.19
1.83
2.7
2.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
14
66
2.12
1.81
2.6
2.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
30
183
1.64
1.81
1.3
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
18
94
1.92
1.79
1.2
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
39
256
1.53
1.75
2.5
3.6
mg/l
7.4
7.9
0.22
27
207
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
187
2237
0.83
1.73
1.4
1.5
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
7
24
2.92
1.72
1.1
1.3
%
1.5
1.4
—
7
24
(3002619) Bacteria identified in Specimen by Culture
26
155
1.68
1.72
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
710
6492
1.10
1.70
4.3
3.6
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
21
118
1.78
1.69
1.5
1.8
pmol/l
34.8
54.6
0.74
16
95
(40768800) Prostate Pathology biopsy report
125
1553
0.80
1.69
1.2
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
18
319
0.56
1.67
1.5
1.5
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
10
42
2.38
1.67
1.2
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
36
235
1.53
1.67
1.3
1.3
%
56.2
53.9
0.13
28
196
(40757494) Bilirubin.total [Moles/volume] in Blood
61
442
1.38
1.66
2.5
2.5
umol/l
64.4
23.3
—
10
41
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
50
353
1.42
1.59
2.4
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
703
6457
1.10
1.55
1.9
1.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
186
1567
1.19
1.54
2.5
1.9
nmol/l
1.2
0.8
4.01
157
1323
(3049233) Organic acids panel - Urine
5
15
3.33
1.52
1.0
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
5
15
3.33
1.52
2.0
2.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
59
433
1.36
1.52
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
30
193
1.56
1.50
1.2
1.4
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
20
116
1.73
1.48
1.2
1.3
%
73.4
53.2
—
10
51
(3020123) Porphyrins [Interpretation] in Serum or Plasma
10
45
2.22
1.46
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
65
488
1.33
1.46
5.5
6.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
17
95
1.79
1.42
12.6
9.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
76
586
1.30
1.42
1.6
2.0
mmol/l
7.1
6.7
0.74
61
403
(3039443) Prostate specific Ag panel - Serum or Plasma
107
1321
0.81
1.41
1.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1253
11825
1.07
1.41
1.5
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
10
46
2.18
1.39
1.3
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
19
112
1.70
1.35
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
17
97
1.75
1.34
1.8
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
211
2434
0.86
1.33
1.6
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
48
350
1.37
1.32
1.1
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
13
69
1.89
1.28
1.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
12
62
1.94
1.27
1.6
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
47
344
1.37
1.27
2.4
2.2
umol/l
60.6
55.5
0.42
36
281
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
67
518
1.30
1.26
2.1
1.8
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
14
77
1.82
1.25
1.1
1.4
pmol/l
14.2
20.6
0.35
14
70
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
791
8467
0.93
1.24
1.7
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
83
1034
0.80
1.23
1.3
1.3
mmol/l
7.5
7.4
0.08
68
767
(3040893) Potassium [Moles/volume] in Capillary blood
6
26
2.31
1.18
1.7
2.3
mmol/l
4.1
4.5
—
6
26
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
34
239
1.42
1.17
2.2
3.0
au/ml
65.4
133.6
—
5
38
(3025130) Human papilloma virus identified in Specimen
114
947
1.21
1.17
1.7
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
767
7175
1.08
1.15
2.0
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7620
75457
1.05
1.15
5.0
4.6
mmol/l
6.0
5.9
2.91
6950
68780
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
39
529
0.74
1.12
1.2
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
11
58
1.90
1.12
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
24
159
1.51
1.11
1.3
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
10
51
1.96
1.11
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
93
763
1.22
1.10
1.3
1.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
31
218
1.42
1.08
1.1
1.1
u/ml
0.5
2.9
1.65
21
121
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
30
210
1.43
1.07
1.3
1.3
%
36.5
36.2
0.02
21
141
(3009015) Lactate [Moles/volume] in Synovial fluid
15
89
1.69
1.07
1.3
1.2
mmol/l
5.5
6.5
—
10
41
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
29
203
1.43
1.04
9.2
7.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
17
106
1.60
1.02
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
277
3069
0.90
0.99
1.1
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
11
61
1.80
0.98
1.3
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
23
2.17
0.98
5.2
2.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
727
6844
1.07
0.95
1.5
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
27
191
1.41
0.94
1.1
1.2
pmol/l
308.8
270.0
0.21
22
136
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
11
62
1.78
0.94
1.1
1.1
u/l
7.8
14.7
0.65
11
62
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
6
27
2.22
0.93
6.7
6.4
mg/l
2.4
1.3
—
6
22
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
171
0.58
0.91
1.0
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
12
195
0.61
0.90
1.3
1.6
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
29
2.07
0.89
1.2
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
25
177
1.41
0.88
1.4
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
25
178
1.41
0.86
9.3
7.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
43
548
0.78
0.85
1.0
1.0
ng/l
47.2
44.7
0.17
37
378
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
12
72
1.67
0.85
1.1
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
43
545
0.79
0.82
1.0
1.0
ng/l
701.4
714.9
0.09
35
370
(4146454)
72
863
0.83
0.82
2.7
2.7
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
73
1.64
0.81
1.2
1.7
umol/l
43.9
42.3
0.07
12
73
(3013139) Helicobacter pylori Ag [Presence] in Stool
560
5261
1.07
0.81
1.3
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
43
544
0.79
0.81
1.0
1.0
ng/l
322.0
333.8
0.13
37
384
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
13
81
1.61
0.81
2.2
2.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
74
617
1.20
0.81
1.3
1.5
promille
1.3
1.3
0.08
56
467
(4094501)
190
2118
0.89
0.80
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
97
830
1.17
0.79
1.5
1.5
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
25
181
1.38
0.79
1.3
1.3
mu/l
91.8
70.6
0.21
18
136
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
0.1
—
0
9
(40758358) Immune stain study
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
94
803
1.17
0.79
1.7
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
233
2559
0.91
0.76
1.9
1.8
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
9
53
1.70
0.75
1.0
2.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
9
53
1.70
0.75
1.1
1.5
umol/24h
524.1
320.7
—
9
53
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
426
3979
1.07
0.74
1.0
1.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
24
2.08
0.74
1.0
1.2
mmol/l
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
54
1.67
0.74
1.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
10
60
1.67
0.72
1.2
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
17
117
1.45
0.71
1.2
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
34
264
1.29
0.71
1.8
1.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
161
1442
1.12
0.71
1.2
1.1
u/ml
1.6
1.5
0.03
76
602
(3007463) Buprenorphine [Presence] in Urine
5
26
1.92
0.70
3.6
6.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7225
71691
1.03
0.69
6.3
5.8
mmol/mol
39.9
39.8
0.14
6649
66277
(40758047) Lysozyme [Mass/volume] in Pleural fluid
13
85
1.53
0.68
1.1
1.2
mg/l
9.0
9.1
0.03
13
77
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
71
835
0.85
0.68
1.1
1.0
u/ml
0.4
0.3
0.07
18
211
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
5
27
1.85
0.68
1.2
1.3
nmol/l
309.7
447.1
—
5
27
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
27
351
0.77
0.66
1.1
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
132
1178
1.12
0.64
1.1
1.1
u/ml
4.0
1.7
0.55
30
296
(3011335) Digoxin [Mass/volume] in Serum or Plasma
10
63
1.59
0.61
1.6
2.3
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
16
113
1.42
0.61
1.2
1.1
ug/l
68.4
76.4
—
8
93
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
13
89
1.46
0.57
2.2
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
103
1159
0.89
0.57
1.5
1.5
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
37
1.62
0.55
7.7
7.3
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
12
82
1.46
0.54
1.3
1.1
u/ml
0.9
1.6
0.26
12
62
(3008898) HLA-B27 [Presence]
271
2534
1.07
0.52
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
40
475
0.84
0.48
1.1
1.3
—
1.5
—
0
29
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
24
190
1.26
0.47
1.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
111
1006
1.10
0.46
2.8
2.1
mg/l
26.8
23.9
0.17
29
263
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
85
0.59
0.45
1.2
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
148
1363
1.09
0.44
1.7
1.7
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
5
31
1.61
0.43
1.8
1.2
mg/l
1.7
1.8
—
5
25
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
266
2509
1.06
0.42
1.6
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
47
406
1.16
0.42
2.3
2.1
ug/min
63.7
165.5
0.74
13
95
(3025296) Carrot IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
3.7
—
0
8
(3036670) Protein [Mass/volume] in Synovial fluid
29
240
1.21
0.41
1.4
1.2
g/l
41.8
38.3
0.74
18
129
(3022670) pH of Venous cord blood
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
34
402
0.85
0.41
1.2
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
37
314
1.18
0.41
3.6
2.5
—
—
—
0
0
(4038314)
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(4133840)
24
195
1.23
0.40
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
138
1277
1.08
0.39
1.3
1.2
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
11950.0
—
0
7
(3017509) Phencyclidine [Presence] in Urine
10
72
1.39
0.36
1.4
1.6
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
16
128
1.25
0.31
1.3
1.1
u/ml
3.5
7.7
0.34
16
96
(3000285) Sodium [Moles/volume] in Blood
14
110
1.27
0.31
1.2
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
36
316
1.14
0.29
2.0
1.8
—
—
—
0
0
(4211845)
48
430
1.12
0.28
2.7
3.4
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
11
85
1.29
0.28
1.5
1.3
—
577.5
—
0
10
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
64
1.25
0.27
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
80
864
0.93
0.26
1.5
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
13
104
1.25
0.26
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2658
26859
0.99
0.26
3.2
2.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
27
234
1.15
0.26
1.2
1.5
ug/l
9.8
8.7
0.51
27
234
(3021706) Oxygen [Partial pressure] in Arterial cord blood
5
71
0.70
0.26
1.0
1.0
kpa
3.5
3.3
—
5
62
(3015183) Erythrocyte sedimentation rate
38
339
1.12
0.25
1.3
1.3
—
—
—
0
0
(4024509)
74
799
0.93
0.25
1.8
1.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
11
137
0.80
0.24
1.1
1.1
u/ml
66.1
56.0
0.22
11
129
(3015076) Soybean IgE Ab [Units/volume] in Serum
43
389
1.11
0.23
1.1
1.0
u/ml
0.3
1.6
—
6
63
(40761995) Spermatozoa Progressive [#/volume] in Semen
18
153
1.18
0.22
3.2
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
18
153
1.18
0.22
6.3
6.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
11
135
0.81
0.22
3.6
6.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
381
3918
0.97
0.21
1.8
1.9
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
16
135
1.19
0.21
10.6
7.4
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
40
364
1.10
0.20
11.8
10.9
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
16
137
1.17
0.18
1.7
2.9
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
32
353
0.91
0.18
1.1
1.1
u/ml
9.6
5.0
—
6
60
(3008401) Mugwort IgE Ab [Units/volume] in Serum
121
1262
0.96
0.16
1.1
1.1
u/ml
0.4
1.0
2.43
61
553
(3000034) Microalbumin [Mass/volume] in Urine
79
750
1.05
0.15
3.8
3.0
mg/l
102.4
49.0
0.70
59
555
(3026470) Cobalt [Mass/volume] in Blood
49
524
0.93
0.15
1.9
2.0
ug/l
3.4
3.8
0.24
42
460
(42870560) Thyrotropin [Units/volume] in Cord blood
9
81
1.11
0.15
1.0
1.0
mu/l
7.8
8.3
—
9
73
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
7359
73743
0.99
0.14
4.4
4.0
mmol/l
1.4
1.3
22.09
6735
67347
(3025577) Chromium [Mass/volume] in Blood
48
510
0.94
0.13
1.9
2.1
ug/l
2.6
2.6
0.03
38
425
(3037556) Urate [Mass/volume] in Serum or Plasma
22
242
0.91
0.13
1.5
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
41
437
0.94
0.12
1.1
1.1
u/ml
11.3
1.7
0.44
17
120
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
14
157
0.89
0.11
1.2
1.3
mg/l
0.8
102.5
—
8
119
(3006462) Nitrate [Presence] in Urine
42
398
1.06
0.10
2.6
3.5
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
5
46
1.09
0.09
1.0
1.0
u/ml
2.5
3.3
—
5
37
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
6
71
0.84
0.07
1.0
1.0
—
-2.6
—
0
21
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
6
71
0.84
0.07
1.0
1.0
kpa
7.5
7.4
—
6
62
(3006598) pH of Arterial cord blood
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
118
1208
0.98
0.07
1.1
1.1
iu/ml
84.5
8223.6
0.54
23
290
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
100
1025
0.98
0.07
1.8
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
84
0.83
0.07
1.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
93
0.86
0.06
1.4
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
50
518
0.97
0.06
1.8
1.3
pmol/l
997.1
125.4
0.47
29
153
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2454
24616
1.00
0.06
4.8
5.0
ug/l
3.9
3.3
0.47
2156
22082
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
306
3090
0.99
0.05
1.7
1.9
—
—
—
0
0
(4015189)
24
230
1.04
0.03
2.2
2.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
44
430
1.02
0.02
1.1
1.1
u/ml
1.9
2.7
0.21
19
133
(3014133) Dog dander IgE Ab [Units/volume] in Serum
100
989
1.01
0.02
1.1
1.1
u/ml
8.4
3.4
0.78
40
395
(3023430) Cat dander IgE Ab [Units/volume] in Serum
93
921
1.01
0.01
1.1
1.1
u/ml
2.0
4.0
1.62
39
377
(3022689) Creatine [Moles/volume] in Urine
24
233
1.03
0.01
1.7
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
130
1308
0.99
0.01
1.1
1.1
u/ml
2.8
4.7
1.60
76
677
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
40
394
1.02
0.00
1.4
1.5
mmol/l
8.0
8.0
0.00
24
246
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
11
106
1.04
0.00
1.1
1.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
12
117
1.03
0.00
1.2
1.1
—
—
—
0
0
(44806420)
21
215
0.98
0.00
2.2
2.4
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
16.1
—
0
6
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
7
0.00
0.00
0.0
9.9
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
6
60
1.00
0.00
1.0
1.0
u/ml
0.0
1.0
—
6
37
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
66.6
—
0
7
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
90
1.00
0.00
1.0
1.2
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
8.2
—
15.0
—
0
5
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
7
0.00
0.00
0.0
1.1
—
42.2
—
0
7
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
82
0.98
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_BLOODOTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_BLOODOTHER | 3.195 [2.89, 3.53] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 7704 out of 25972 females with D3_BLOODOTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_BLOODOTHER | 3.295 [2.94, 3.69] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 7471 out of 21167 males with D3_BLOODOTHER died.
Mortality risk
Mortality risk for people of age
years, who have D3_BLOODOTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.244% | 0.68% |
| 5 | 1.523% | 3.577% |
| 10 | 3.825% | 8.513% |
| 15 | 7.013% | 16.125% |
| 20 | 12.503% | 26.374% |
Relationships between endpoints
↥Index endpoint: D3_BLOODOTHER – Other diseases of blood and blood-forming organs, wide
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data